Original Article
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
N Engl J Med 2005; 352:1436-1444April 7, 2005
- Abstract
Background
Methicillin-resistant Staphylococcus aureus (MRSA) infection has emerged in patients who do not have the established risk factors. The national burden and clinical effect of this novel presentation of MRSA disease are unclear.
Methods
We evaluated MRSA infections in patients identified from population-based surveillance in Baltimore and Atlanta and from hospital-laboratory–based sentinel surveillance of 12 hospitals in Minnesota. Information was obtained by interviewing patients and by reviewing their medical records. Infections were classified as community-acquired MRSA disease if no established risk factors were identified.
Results
From 2001 through 2002, 1647 cases of community-acquired MRSA infection were reported, representing between 8 and 20 percent of all MRSA isolates. The annual disease incidence varied according to site (25.7 cases per 100,000 population in Atlanta vs. 18.0 per 100,000 in Baltimore) and was significantly higher among persons less than two years old than among those who were two years of age or older (relative risk, 1.51; 95 percent confidence interval, 1.19 to 1.92) and among blacks than among whites in Atlanta (age-adjusted relative risk, 2.74; 95 percent confidence interval, 2.44 to 3.07). Six percent of cases were invasive, and 77 percent involved skin and soft tissue. The infecting strain of MRSA was often (73 percent) resistant to prescribed antimicrobial agents. Among patients with skin or soft-tissue infections, therapy to which the infecting strain was resistant did not appear to be associated with adverse patient-reported outcomes. Overall, 23 percent of patients were hospitalized for the MRSA infection.
Conclusions
Community-associated MRSA infections are now a common and serious problem. These infections usually involve the skin, especially among children, and hospitalization is common.
Media in This Article
Figure 1
Incidence of Community-Associated MRSA Disease in Atlanta and Baltimore, According to Race and Age Group.Table 1
Infections and Outcomes Associated with Community-Associated MRSA Disease, 2001–2002.Article Activity
- Article
In the United States, Staphylococcus aureus is the most common cause of skin and soft-tissue infections, as well as of invasive infections acquired in hospitals.1,2 Treatment of serious S. aureus infections can be challenging, and the associated mortality rate remains 20 to 25 percent despite the availability of highly active antimicrobial agents.3,4 However, most antistaphylococcal agents are ineffective against methicillin-resistant S. aureus (MRSA), which was first identified as a hospital-acquired pathogen in the 1960s.2,3,5,6
Over the past 40 years, MRSA infections have become endemic in most U.S. hospitals1,2 and hospitals worldwide,7 striking, with rare exception, only patients with established risk factors.8,9 More recently, however, MRSA infections have been described in patients without established risk factors who are living in the community.10-19 The current approach to suspected cases of community-associated (also referred to as community-acquired) S. aureus infections (suggested by findings of furuncles, abscesses, or cellulitis) commonly includes empirical treatment with β-lactam antibiotics. This approach may need to be reconsidered if community-associated MRSA becomes a clinically significant pathogen.
The Centers for Disease Control and Prevention (CDC) and three sites participating in the Emerging Infections Program began a specialized MRSA surveillance project in 2001 using the Active Bacterial Core Surveillance program, a population-based surveillance component of the Emerging Infections Program Network designed to study the epidemiologic features of invasive bacterial disease and to track drug resistance in the United States. We used these data to evaluate the incidence of endemic community-associated MRSA infection, racial disparities in the incidence, patterns of antimicrobial susceptibility, and clinical outcomes in several areas in the United States.
Methods
Surveillance Population
The MRSA Active Bacterial Core Surveillance project monitored all MRSA isolates from all body sites from patients in 11 Baltimore hospitals serving a population of 700,000; Health District 3 in greater Atlanta, comprising eight counties with a total population of 3.3 million; and 12 sentinel hospital–based laboratories representative of the state in Minnesota (6 rural and 6 urban, representing 16 percent of the licensed hospital beds in the state). Laboratories served both outpatient clinic networks and hospital inpatients; sites in Atlanta included several referral laboratories serving predominantly ambulatory care settings. Surveillance was performed consecutively for 12 months in Baltimore (beginning February 2002), 18 months in Atlanta (beginning July 2001), and 24 months in Minnesota (beginning January 2001). In Baltimore, 1 of 12 eligible hospitals declined to participate in the MRSA study; however, this omission would be unlikely to have a substantial effect. The laboratory in that hospital historically reports only about 5 percent of the cases of infections with other pathogens under surveillance as part of the Active Bacterial Core Surveillance system in Baltimore.
Case Definitions and Ascertainment
A community-associated MRSA isolate was defined as an MRSA isolate recovered from a clinical culture from a patient residing in the surveillance area who had no established risk factors for MRSA infection. Established risk factors included the isolation of MRSA two or more days after hospitalization; a history of hospitalization, surgery, dialysis, or residence in a long-term care facility within one year before the MRSA-culture date; the presence of a permanent indwelling catheter or percutaneous medical device (e.g., tracheostomy tube, gastrostomy tube, or Foley catheter) at the time of culture; or previous isolation of MRSA. We reviewed the medical records of patients with suspected community-associated MRSA isolates to identify risk factors for infection. We attempted to interview by telephone all patients for whom no risk factors were identified to confirm the absence of established risk factors and to obtain a brief history of the clinical outcome. At least 15 attempts were made, after which suspected community-associated MRSA isolates were classified as confirmed in the case of patients who were successfully interviewed and confirmed to have no established risk factors or as probable in the case of patients who were not interviewed but who had no established risk factors on a review of medical records. The remaining isolates were classified as either health care–associated when established risk factors were identified or indeterminate if no information on the patient could be obtained.
A case of community-associated MRSA disease was defined as illness compatible with staphylococcal disease in a patient residing in the surveillance areas and isolation of community-associated MRSA from a clinically relevant site. Only a subgroup of patients with community-associated MRSA isolates had actual disease and achieved case status.
To identify cases, surveillance personnel routinely contacted all clinical microbiology laboratories serving residents of each catchment area regarding MRSA isolated from clinical cultures (infection-control surveillance cultures were excluded). Periodic audits of laboratory records were conducted by surveillance personnel to identify any unreported cases and ensure the completeness of reporting. Surveillance personnel collected information on patients using a standardized questionnaire that included demographic and isolate data on all MRSA isolates; information on antimicrobial-susceptibility testing (with results characterized as susceptible, intermediate, or resistant) and clinical characteristics were obtained from available medical records (e.g., emergency room, primary care, or hospital) only for patients with confirmed or probable community-associated MRSA isolates. The collection of additional data on disease outcome, employment status, household structure, socioeconomic status, and level of education was limited to patients with confirmed cases of community-associated MRSA disease.
The study was approved by the appropriate institutional review boards at the participating sites, including all participating Baltimore hospitals, the Maryland Department of Health and Mental Hygiene, Johns Hopkins University Bloomberg School of Public Health, the Georgia Department of Human Resources, Emory University School of Medicine, the Minnesota Department of Health, and the CDC. Oral informed consent was obtained from all those who were interviewed.
Statistical Analysis
Statistical analysis was conducted with SAS software (SAS Institute). Annual cumulative incidence rates were calculated, after adjustment for the study period at each site, with the use of projections of the 2001 and 2002 population from the Census Bureau. Initial therapy was categorized as active if the patient received an antimicrobial agent with activity against S. aureus and to which the MRSA was susceptible in vitro. Therapy was categorized as inactive if initial therapy consisted of antimicrobial agents to which the isolate had intermediate resistance on testing or was resistant in vitro. If the results of susceptibility testing were not available for a prescribed agent or the patient received no antimicrobial agents, the patient was excluded from analyses correlating inactive therapy and outcomes. The Mantel–Haenszel chi-square test was used to compare the incidence according to race and other categorical data, and the t-test was used for continuous data. All comparisons were initially stratified according to the reporting area, and rate ratios were pooled if there were no significant differences between areas according to the Breslow–Day test for homogeneity of the rate ratios.
Results
Surveillance
During the study period, 12,553 patients with MRSA isolates were reported. Of these patients, 9972 (79 percent) were immediately classified as having health care–associated MRSA infection and did not require interviews. Interviews were attempted with 2581 patients with suspected cases of community-associated MRSA infection; 1063 of these patients (41 percent) were interviewed, allowing 280 (11 percent) to be reclassified as having health care–associated MRSA. Among the remaining patients with suspected cases of community-associated MRSA infection, 2107 (17 percent) were classified as having confirmed or probable community-associated MRSA isolates (Atlanta, 1590 of 7819 [20 percent]; Minnesota, 370 of 3714 [12 percent]; and Baltimore, 147 of 1720 [8 percent]; P<0.001). MRSA isolates in 196 patients were classified as indeterminate (2 percent).
The overall incidence of invasive MRSA infection (i.e., MRSA recovered from a normally sterile site), regardless of whether the infection was acquired in the community or at a health care facility, was 19.3 infections per 100,000 population in Atlanta and 40.4 infections per 100,000 in Baltimore.
Of the 2107 confirmed or probable isolates of community-associated MRSA, 1647 (78 percent) were associated with clinical illness and were classified as cases of community-associated MRSA disease. Among these cases, the confirmed and the probable community-associated MRSA isolates were obtained from similar body sites and demonstrated similar susceptibilities to antimicrobial agents with one exception, i.e., there was variable sensitivity to erythromycin (details are provided in the Supplementary Appendix, available with the full text of this article at www.nejm.org). The annual incidence of community-associated MRSA disease in the two areas that performed population-based surveillance was 25.7 cases per 100,000 in Atlanta and 18.0 per 100,000 in Baltimore (rate ratio, 0.70; 95 percent confidence interval, 0.58 to 0.85) (Figure 1Figure 1
Incidence of Community-Associated MRSA Disease in Atlanta and Baltimore, According to Race and Age Group.). In both surveillance areas, the incidence was significantly higher among persons who were less than two years old than among those who were two years of age or older (unadjusted relative risk, 1.51; 95 percent confidence interval, 1.19 to 1.92) (Figure 1). Incidence rates were significantly higher among blacks than whites in Atlanta among all age groups (age-adjusted relative risk, 2.74; 95 percent confidence interval, 2.44 to 3.07); racial differences in incidence were not significant in the Baltimore population, even in the youngest age group (relative risk, 2.58; 95 percent confidence interval, 0.31 to 21.5).Clinical Characteristics
The type of infection varied slightly among the surveillance areas (Table 1Table 1
Infections and Outcomes Associated with Community-Associated MRSA Disease, 2001–2002.); of the 1647 patients with community-associated MRSA disease, most (1266 [77 percent]) were categorized as having skin or soft-tissue infections. Specific types included abscess in 751 patients (59 percent), cellulitis in 528 patients (42 percent), folliculitis in 88 patients (7 percent), and impetigo in 33 patients (3 percent). Among the other types of infection reported, 103 (6 percent) were invasive, including bacteremia, septic arthritis, and osteomyelitis; 157 were in wounds (10 percent); and 31 were pneumonia (2 percent) (Table 1).Most patients (1333 [81 percent]) were treated with antimicrobial agents; specific antimicrobial agents were documented for 1297 patients (97 percent). Among these 1297 patients, 757 (58 percent) received β-lactam antibiotics alone, 199 (15 percent) received a β-lactam with a non–β-lactam agent, and 341 (26 percent) received only non–β-lactam therapy. Among the patients whose antibiotic regimens were documented, significantly more of the 1099 patients with skin infections than of the 198 patients with other types of infection received β-lactam agents alone (64 percent vs. 28 percent, P<0.001).
Antimicrobial susceptibilities were obtained from the medical records of 1345 of the 1647 patients with community-associated MRSA disease (82 percent). With few exceptions, the patterns of susceptibility were similar among the study areas. However, isolates from patients in Atlanta and Baltimore were significantly less likely than those from Minnesota to be susceptible to erythromycin and ciprofloxacin (Table 2Table 2
Number of Community-Associated MRSA Isolates That Were Susceptible to Selected Antimicrobial Agents, 2001–2002.). Susceptibility data and documented information on empirical therapy were available for most patients who received empirical therapy (1215 of 1297 [94 percent]); 884 (73 percent) received inactive therapy.Limited information on the effect of the disease was available from the medical records; 506 patients (31 percent) were hospitalized, including 371 (23 percent) who were hospitalized specifically for MRSA disease (Table 1). For these 371 patients, hospitalization was unlikely to be the result of the clinician's receiving the MRSA-culture report. The interval between specimen collection and admission was less than one day for 226 of the 371 patients (61 percent), one to two days for 115 (31 percent), and more than two days for 22 (6 percent) (2 percent had missing data). A total of 37 patients (10 percent) required hospitalization in the intensive care unit. Hospitalization lasted a median of four days, and only 1 of the 37 patients who died during hospitalization had documentation that the community-associated MRSA was causal or contributory to the death.
Information on other outcomes associated with community-associated MRSA infection was available for 575 patients with confirmed cases (i.e., interviewed patients). Among these patients, 560 (97 percent) received some antimicrobial agents, 136 (24 percent) were hospitalized, 226 (39 percent) underwent incision and drainage, and 176 (31 percent) required a follow-up visit with their physician.
To assess the relationship between inactive antimicrobial therapy and outcome more closely, we attempted to identify a homogeneous group of patients in which to compare clinical outcomes on the basis of empirical antimicrobial treatment. We limited further analysis to 453 patients with confirmed cases of community-associated MRSA disease involving skin or soft-tissue infections who received antimicrobial therapy at the time of the isolation of community-associated MRSA and for whom information on initial treatment and clinical outcome was available from the interview. Neither initial incision and drainage nor initial antimicrobial therapy that was inactive was significantly associated with an increased frequency of the following patient-reported outcomes after the initial evaluation for illness: follow-up visits to a health care provider, subsequent incision and drainage, or subsequent change in antimicrobial therapy (Table 3Table 3
Effect of Initial Therapy on Selected Outcomes among 453 Patients with Confirmed Skin or Soft-Tissue Infections Due to Community-Associated MRSA, 2001–2002.). Also, among the subgroup of patients who did not initially undergo incision and drainage, there were no significant differences in outcomes according to whether the initial therapy was inactive (Table 3).Potential Exposures to MRSA
Although none of the established risk factors for MRSA infection were documented in any patient, 744 patients (45 percent) had underlying conditions or factors that were associated with skin infections or suggested some contact with the health care system. Among the 1250 patients whose age was known to be at least 18 years, 653 (52 percent) reported 1249 underlying conditions, including smoking (35 percent), previous skin infections (21 percent), diabetes (19 percent), asthma (12 percent), infection with the human immunodeficiency virus (HIV) (9 percent), intravenous drug use (7 percent), alcohol abuse (6 percent), and coronary vascular disease (5 percent). Among 345 patients who were younger than 18 years old, 76 (22 percent) reported 90 preexisting conditions, including skin disease (42 percent), asthma (35 percent), and smoking (7 percent). Among the 575 patients with confirmed community-associated MRSA disease, detailed information on household characteristics and employment status was obtained from the interview, and several points of contact with the health care system exclusive of established risk factors for MRSA infection were identified (Table 4Table 4
Frequency of Characteristics Potentially Related to Infection among 575 Patients with Confirmed Community-Associated MRSA Disease, 2001–2002.).Discussion
In this study, 8 to 20 percent of all MRSA isolates collected as part of prospective population-based surveillance were not associated with traditional risk factors and were classified as community-associated MRSA. Most of these isolates were associated with clinically relevant infections that required treatment. The most common infections involved skin and soft tissues; however, 6 percent were considered invasive. Attributable mortality was low, but 23 percent of patients were hospitalized for these infections.
The incidence of clinically relevant community-associated MRSA disease varied between the Atlanta surveillance area (25.7 per 100,000) and the Baltimore surveillance area (18.0 per 100,000), and we found marked disparity in the incidence of community-associated MRSA disease between blacks and whites in Atlanta but not in Baltimore, even among the youngest age group. Several reports have highlighted the increased incidence of staphylococcal disease among Pacific Islanders, American Indians, and Alaskan Natives.16,18,22,23 Black race was associated with increased rates of invasive S. aureus disease in 1998 in one population-based study in Connecticut24 and in other studies evaluating invasive pneumococcal disease.25-28 The increased prevalence of certain underlying diseases (e.g., diabetes and HIV infection), differences in immune response, or differences in other socioeconomic factors (e.g., crowding in the household or decreased access to medical care), which are correlated with black race, may contribute to these findings.29
The differences observed in incidence rates between Baltimore and Atlanta can probably be explained on the basis of the different populations under surveillance. The lower overall incidence of community-associated MRSA disease in Baltimore suggests that this surveillance population may be more likely to have established risk factors for MRSA infection. The incidence may also be falsely low, since 1 of 12 eligible laboratories declined to participate in the study. However, it is unlikely that the Baltimore surveillance underreported cases from the remaining laboratories, since the rates of invasive MRSA disease (regardless of whether the infection was acquired in the community or at a health care facility) were higher in Baltimore (40 per 100,000) than Atlanta (19 per 100,000). The Atlanta surveillance area encompassed an eight-county urban and suburban area and included a large referral laboratory; the Baltimore surveillance area was limited to urban hospital-based laboratories likely to serve persons with more frequent contact with the hospitals.
Our large, prospective series of community-associated MRSA infections identified with the use of standardized methods to measure rates of endemic disease allows for an accurate description of the clinical course and effect of these infections. In a manner consistent with previous reports from outbreaks and smaller surveillance studies, we found that most patients who were treated empirically received β-lactam antimicrobial agents. Measuring the effect of inactive therapy on these infections has been difficult owing to the small numbers of cases and imprecise outcome measurements.30-35 Although we relied on self-reported measures, our data suggest that patients with community-associated MRSA skin or soft-tissue disease who initially receive inactive antimicrobial therapy have outcomes similar to those among patients who are treated with antimicrobial agents to which the organism is susceptible in vitro. Prospective evaluations with more objective measurements are needed to clarify whether the addition of active systemic therapy to topical agents or surgical drainage increases the beneficial effect in patients with community-associated MRSA infections involving the skin and soft tissues.
Our report reflects the results of one to two years of active surveillance in three large and diverse geographic areas. However, certain limitations should be borne in mind. First, we were unable to perform population-based estimates in Minnesota, where sentinel surveillance was conducted. However, the descriptive data probably reflect the patient mix in that state. Second, our surveillance required isolation of MRSA from a clinically relevant culture; since S. aureus skin disease is often treated empirically without a diagnostic test, our results probably underestimate the true burden of disease. Some caution must be taken in generalizing our findings to the U.S. population. First, we were able to interview only 41 percent of eligible patients, eliminating a majority of patients from the outcome analysis. Second, although there were rarely significant differences among the reporting areas, the majority of cases were reported in the Atlanta area. Also, patients who could not be interviewed may have been misclassified as having community-associated MRSA infection, since no interview data were available. However, we believe pooling the patients with probable and confirmed cases of community-associated MRSA disease was justified on the basis of the similarities between both patients' and isolates' characteristics, reflecting a pattern typically seen in previously reported outbreaks of community-associated MRSA infection.10,11,15,36-38
To avoid clinical complications from community-acquired MRSA infections, clinicians should now consider MRSA as a potential pathogen in patients with suspected S. aureus infections in the community setting. Clinicians should obtain appropriate material for bacterial culture; should follow up on the results of susceptibility testing of all S. aureus isolates, since by definition MRSA organisms are not susceptible to β-lactam antibiotics; and should recommend surgical drainage of infections when feasible. The choice of appropriate antimicrobial agents for suspected S. aureus infections of skin and soft tissue in patients in the community must now take into account the emergence of community-associated MRSA; providers should be aware that several available antimicrobial agents should be effective in treating these infections.
Supported by the CDC Emerging Infections Program. (The use of product names in this article does not imply their endorsement by the Public Health Service or the Department of Health and Human Services.)
We are indebted to Virginia Rego, Wendy Baughman, Christina Payne, Matthew Johns, Margaret Pass, Elizabeth Hopewell, Chris Van Beneden, Tami Hilger, Anne Schuchat, and personnel in hospitals and laboratories participating in the Community-Associated MRSA Special Project of the Active Bacterial Core Surveillance program for their contributions to this project.
Source Information
From the Division of Bacterial and Mycotic Diseases (S.K.F.) and Division of Healthcare Quality Promotion (J.C.H., M.M., J.A.J.), National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta; Emory University School of Medicine and the Veterans Affairs Medical Center, Atlanta (M.M., J.A.J., M.M.F.); Johns Hopkins University Bloomberg School of Public Health, Baltimore (L.T.S., L.H.H.); and the Minnesota Department of Health, Minneapolis (K.C.-S., K.H., R.L.).
Address reprint requests to Dr. Fridkin at the CDC, NCID, DBMD, MDB, MS C-09, 1600 Clifton Rd., NE, Atlanta, GA 30333, or at skf0@cdc.gov.
- References
References
1
National Nosocomial Infections Surveillance System
CrossRef | Web of Science | Medline2
Chambers HF . The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001;7:178-182
CrossRef | Web of Science | Medline3
Archer GL . Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 1998;26:1179-1181
CrossRef | Web of Science | Medline4
Cosgrove SE ,Sakoulas G ,Perencevich EN ,Schwaber MJ ,Karchmer AW ,Carmeli Y . Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53-59
CrossRef | Web of Science | Medline5
Jorgensen JH . Laboratory and epidemiologic experience with methicillin-resistant Staphylococcus aureus in the USA. Eur J Clin Microbiol 1986;5:693-696
CrossRef | Medline6
Barrett FF ,McGehee RF Jr ,Finland M . Methicillin-resistant Staphylococcus aureus at Boston City Hospital: bacteriologic and epidemiologic observations. N Engl J Med 1968;279:441-448
Full Text | Web of Science | Medline7
Diekema DJ ,Pfaller MA ,Schmitz FJ , et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32:S114-S132
CrossRef | Web of Science | Medline8
Lowy F . Staphylococcus aureus infections. N Engl J Med 1998;339:520-532
Full Text | Web of Science | Medline9
Brumfitt W ,Hamilton-Miller J . Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989;320:1188-1196
Full Text | Web of Science | Medline10
Methicillin-resistant Staphylococcus aureus infections in correctional facilities -- Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 2003;52:992-996
Medline11
Methicillin-resistant Staphylococcus aureus infections among competitive sports participants -- Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 2003;52:793-795
Medline12
Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections -- Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2003;52:88-88
Medline13
Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison -- Mississippi, 2000. JAMA 2002;287:181-182
CrossRef | Web of Science14
Herold BC ,Immergluck LC ,Maranan MC , et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-598
CrossRef | Web of Science | Medline15
Naimi TS ,LeDell KH ,Como-Sabetti K , et al. Community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-2984
CrossRef | Web of Science | Medline16
Groom AV ,Wolsey DH ,Naimi TS , et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001;286:1201-1205
CrossRef | Web of Science | Medline17
Gorak EJ ,Yamada SM ,Brown JD . Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999;29:797-800
CrossRef | Web of Science | Medline18
Baggett HC ,Hennessy TW ,Leman R , et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol 2003;24:397-402
CrossRef | Web of Science | Medline19
Sattler CA ,Mason EO Jr ,Kaplan SL . Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 2002;21:910-917
CrossRef | Web of Science | Medline20
Raney PM ,Williams PP ,McGowan JE ,Tenover FC . Validation of Vitek version 7.01 software for testing staphylococci against vancomycin. Diagn Microbiol Infect Dis 2002;43:135-140
CrossRef | Web of Science | Medline21
Fridkin SK ,Hageman J ,McDougal LK , et al. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis 2003;36:429-439
CrossRef | Web of Science | Medline22
Taylor G ,Kirkland T ,Kowalewska-Grochowska K ,Wang Y . A multistrain cluster of methicillin-resistant Staphylococcus aureus based in a native community. Can J Infect Dis 1990;1:121-12623
Community-associated methicillin-resistant Staphylococcus aureus infections in Pacific Islanders -- Hawaii, 2001-2003. MMWR Morb Mortal Wkly Rep 2004;53:767-770
Medline24
Morin CA ,Hadler JL . Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 2001;184:1029-1034
CrossRef | Web of Science | Medline25
Albanese BA ,Roche JC ,Pass M ,Whitney CG ,McEllistrem MC ,Harrison LH . Geographic, demographic, and seasonal differences in penicillin-resistant Streptococcus pneumoniae in Baltimore. Clin Infect Dis 2002;34:15-21
CrossRef | Web of Science | Medline26
Flannery B ,Schrag S ,Bennett NM , et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA 2004;291:2197-2203
CrossRef | Web of Science | Medline27
Robinson KA ,Baughman W ,Rothrock G , et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001;285:1729-1735
CrossRef | Web of Science | Medline28
Watt JP ,O'Brien KL ,Benin AL , et al. Invasive pneumococcal disease among Navajo adults, 1989-1998. Clin Infect Dis 2004;38:496-501
CrossRef | Web of Science | Medline29
Lorenz E ,Mira JP ,Cornish KL ,Arbour NC ,Schwartz DA . A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000;68:6398-6401
CrossRef | Web of Science | Medline30
Iyer S ,Jones DH . Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol 2004;50:854-858
CrossRef | Web of Science | Medline31
Lee MC ,Rios AM ,Aten MF , et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004;23:123-127
CrossRef | Web of Science | Medline32
Martinez-Aguilar G ,Hammerman WA ,Mason EO Jr ,Kaplan SL . Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003;22:593-598
CrossRef | Web of Science | Medline33
Marcinak JF ,Frank AL . Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Curr Opin Infect Dis 2003;16:265-269
CrossRef | Web of Science | Medline34
Frank AL ,Marcinak JF ,Mangat PD , et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002;21:530-534
CrossRef | Web of Science | Medline35
Daum RS ,Seal JB . Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: our backs to the wall. Crit Care Med 2001;29:Suppl 4:N92-N96
CrossRef | Web of Science | Medline36
Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections -- Los Angeles County, California, 2002-2003. JAMA 2003;289:1377-1377
CrossRef | Web of Science37
Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus -- Minnesota and North Dakota, 1997-1999. JAMA 1999;282:1123-1125
CrossRef | Web of Science38
Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison -- Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001;50:919-922
Medline
- Citing Articles (447)
Citing Articles
1
S. J. van Hal, T. P. Lodise, D. L. Paterson. (2012) The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis. Clinical Infectious Diseases
CrossRef2
Sylvie Parer, Anne Lotthé, Patrick Chardon, Rosie Poncet, Hélène Jean-Pierre, Estelle Jumas-Bilak. (2012) An Outbreak of Heterogeneous Glycopeptide-Intermediate Staphylococcus aureus Related to a Device Source in an Intensive Care Unit. Infection Control and Hospital Epidemiology 33:2, 167-174
CrossRef3
AH Shadyab, NF Crum-Cianflone. (2012) Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature. HIV Medicinen/a-n/a
CrossRef4
Z. Xiao, L. Wu, H. Mo, T. Kong. (2012) Increased T Cell Chemotaxis Response to Staphylococcus Enterotoxin B Mediated Human Endothelial Cell Damage In Vitro. Scandinavian Journal of Immunology 75:2, 147-156
CrossRef5
Nicolas A. Forcade, Nathan P. Wiederhold, Laurajo Ryan, Robert L. Talbert, Christopher R. Frei. (2012) Antibacterials as Adjuncts to Incision and Drainage for Adults with Purulent Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infections. Drugs 72:3, 339-351
CrossRef6
Berta Esteban-Fernández de Ávila, María Pedrero, Susana Campuzano, Vanessa Escamilla-Gómez, José M. Pingarrón. (2012) Sensitive and rapid amperometric magnetoimmunosensor for the determination of Staphylococcus aureus. Analytical and Bioanalytical Chemistry
CrossRef7
Adam Weiss, Harry Dym. (2012) Review of Antibiotics and Indications for Prophylaxis. Dental Clinics of North America 56:1, 235-244
CrossRef8
Robert Skov, Keryn Christiansen, Stephanie J. Dancer, Robert S. Daum, Matthew Dryden, Yhu-Chering Huang, Franklin D. Lowy. (2012) Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA). International Journal of Antimicrobial Agents
CrossRef9
Stefania Stefani, Doo Ryeon Chung, Jodi A. Lindsay, Alex W. Friedrich, Angela M. Kearns, Henrik Westh, Fiona M. MacKenzie. (2012) Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. International Journal of Antimicrobial Agents
CrossRef10
R. Nazareth, J. Gonçalves-Pereira, A. Tavares, M. Miragaia, H. de Lencastre, J. Silvestre, P. Freitas, E. Gonçalves, F. Martins, V. Mendes, C. Tapadinhas, P. Póvoa. (2012) Infeção por staphylococcus aureus meticilina-resistente da comunidade em Portugal. Revista Portuguesa de Pneumologia (English Edition) 18:1, 34-38
CrossRef11
Steven Y. C. Tong, Luke F. Chen, Vance G. Fowler. (2011) Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?. Seminars in Immunopathology
CrossRef12
Wesley G. Lackey, Kyle J. Jeray, Atul F. Kamath, John G. Horneff, John L. Esterhai. 2011. Wound Infections. , 78-85.
CrossRef13
Maria Giusti, Giuseppe Torre, Caterina Aurigemma, Angelo Giuseppe Solimini, Alice Mannocci, Lucia Marinelli, Antonio Boccia. (2011) Knowledge, attitude and behaviour toward MRSA: results from a survey among biomedical students and the general population. Journal of Public Health 19:6, 527-534
CrossRef14
Pascal Del Giudice, Pierre Tattevin, Jérôme Étienne. (2011) Infections à Staphylococcus aureus résistants à la méticilline communautaires. La Presse Médicale
CrossRef15
M. Morgan. (2011) Treatment of MRSA soft tissue infections: An overview. Injury 42, S11-S17
CrossRef16
Rodger Novak. (2011) Are pleuromutilin antibiotics finally fit for human use?. Annals of the New York Academy of Sciences 1241:1, 71-81
CrossRef17
A. M. Rivera, H. W. Boucher. (2011) Current Concepts in Antimicrobial Therapy Against Select Gram-Positive Organisms: Methicillin-Resistant Staphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resistant Enterococci. Mayo Clinic Proceedings 86:12, 1230-1243
CrossRef18
Dawn M. Sievert, Matthew L. Boulton, Mark L. Wilson, Melinda J. Wilkins, Brenda W. Gillespie. (2011) A Multivariable Model to Classify Methicillin-Resistant Staphylococcus aureus Infections as Health Care or Community Associated. Infectious Diseases in Clinical Practice1
CrossRef19
Hisato Ishikawa, Takayuki Sugiyama, Keisuke Kurita, Akihiro Yokoyama. (2011) Synthesis and antimicrobial activity of 2,3-bis(bromomethyl)quinoxaline derivatives. Bioorganic Chemistry
CrossRef20
Clayton D. Harro, Robert F. Betts, Jonathan S. Hartzel, Matthew T. Onorato, Joy Lipka, Steven S. Smugar, Nicholas A. Kartsonis. (2011) The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies. Vaccine
CrossRef21
Brad Spellberg, Robert Daum. (2011) Development of a vaccine against Staphylococcus aureus. Seminars in Immunopathology
CrossRef22
Kevin M. Rigby, Frank R. DeLeo. (2011) Neutrophils in innate host defense against Staphylococcus aureus infections. Seminars in Immunopathology
CrossRef23
A. M. Milstone, B. W. Goldner, T. Ross, J. W. Shepard, K. C. Carroll, T. M. Perl. (2011) Methicillin-Resistant Staphylococcus aureus Colonization and Risk of Subsequent Infection in Critically Ill Children: Importance of Preventing Nosocomial Methicillin-Resistant Staphylococcus aureus Transmission. Clinical Infectious Diseases 53:9, 853-859
CrossRef24
B. Hota, R. Lyles, J. Rim, K. J. Popovich, T. Rice, A. Aroutcheva, R. A. Weinstein, . (2011) Predictors of Clinical Virulence in Community-Onset Methicillin-Resistant Staphylococcus aureus Infections: The Importance of USA300 and Pneumonia. Clinical Infectious Diseases 53:8, 757-765
CrossRef25
Takashi Suzuki. (2011) A New Target for Staphylococcus aureus Associated With Keratitis. Cornea 30, S34-S40
CrossRef26
Craig G. Gunderson. (2011) Cellulitis: Definition, Etiology, and Clinical Features. The American Journal of Medicine
CrossRef27
Monthida Fangtham, Alan N. Baer. (2011) Methicillin-Resistant Staphylococcus aureus Arthritis in Adults: Case Report and Review of the Literature. Seminars in Arthritis and Rheumatism
CrossRef28
Yoshiko MINE, Wataru HIGUCHI, Kiyohito TAIRA, Isamu NAKASONE, Masao TATEYAMA, Tatsuo YAMAMOTO, Hiroshi UEZATO, Kenzo TAKAHASHI. (2011) Nosocomial outbreak of multidrug-resistant USA300 methicillin-resistant Staphylococcus aureus causing severe furuncles and carbuncles in Japan. The Journal of Dermatologyno-no
CrossRef29
Annelise L. Dawson, Robert P. Dellavalle, Dirk M. Elston. (2011) Infectious Skin Diseases: A Review and Needs Assessment. Dermatologic Clinics
CrossRef30
E. Mostofsky, M. Lipsitch, G. Regev-Yochay. (2011) Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?. Journal of Antimicrobial Chemotherapy 66:10, 2199-2214
CrossRef31
Luke F. Chen, Cody Chastain, Deverick J. Anderson. (2011) Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections: Management and Prevention. Current Infectious Disease Reports 13:5, 442-450
CrossRef32
Barry J. Knapp, Sara N. Tsuchitani. (2011) Prevalence of methicillin-resistant Staphylococcus aureus colonization in emergency medical service providers. The American Journal of Emergency Medicine 29:8, 957-958
CrossRef33
Iraj Sedighi, Hoda Jaefari Moez, Mohammad Yousef Alikhani. (2011) Nasal carriage of methicillin resistant <i>Staphylococcus aureus</i> and their antibiotic susceptibility patterns in children attending day-care centers. Acta Microbiologica et Immunologica Hungarica 58:3, 227-234
CrossRef34
Tzu-Chun Lin, Cheng-Huang Chang, Song-Jen Hong, Yeong-Chuan Tsai, Chung-Hsing Chang. (2011) Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections and minocyclin treatment experience in the dermatological setting of eastern Taiwan. Dermatologica Sinica 29:3, 86-90
CrossRef35
E. J. Septimus, R. C. Owens. (2011) Need and Potential of Antimicrobial Stewardship in Community Hospitals. Clinical Infectious Diseases 53:suppl 1, S8-S14
CrossRef36
Jonathan Kei, John R. Richards. (2011) The Prevalence of Methicillin-Resistant Staphylococcus aureus on Inanimate Objects in an Urban Emergency Department. The Journal of Emergency Medicine 41:2, 124-127
CrossRef37
Fei Sun, Lu Zhou, Bing-Chuan Zhao, Xin Deng, Hoonsik Cho, Chengqi Yi, Xing Jian, Chun-Xiao Song, Chi-Hao Luan, Taeok Bae, Zigang Li, Chuan He. (2011) Targeting MgrA-Mediated Virulence Regulation in Staphylococcus aureus. Chemistry & Biology 18:8, 1032-1041
CrossRef38
Michael Edelstein, Angela Kearns, Rebecca Cordery. (2011) Panton-Valentine Leukocidin associated Staphylococcus aureus infections in London, England: Clinical and socio-demographic characterisation, management, burden of disease and associated costs. Journal of Infection and Public Health 4:3, 145-153
CrossRef39
Giovanni Battista Orsi, Marco Falcone, Mario Venditti. (2011) Surveillance and management of multidrug-resistant microorganisms. Expert Review of Anti-infective Therapy 9:8, 653-679
CrossRef40
Kellie Burnside, Lakshmi Rajagopal. (2011) Aspects of eukaryotic-like signaling in Gram-positive cocci: a focus on virulence. Future Microbiology 6:7, 747-761
CrossRef41
Seung Chol Park, Jea Whan Lee, Joung Sik Rim. (2011) Prostatic abscess caused by community-acquired methicillin-resistant Staphylococcus aureus. International Journal of Urology 18:7, 536-538
CrossRef42
J. KIM, C. FERRATO, G. R. GOLDING, M. R. MULVEY, K. A. SIMMONDS, L. W. SVENSON, G. KEAYS, L. CHUI, M. LOVGREN, M. LOUIE. (2011) Changing epidemiology of methicillin-resistant Staphylococcus aureus in Alberta, Canada: population-based surveillance, 2005–2008. Epidemiology and Infection 139:07, 1009-1018
CrossRef43
Shneh Sethi, Mathias Herrmann, Jonas Roller, Lutz von Müller, Ellinor I. Peerschke, Berhane Ghebrehiwet, Irma Bajric, Michael D. Menger, Matthias W. Laschke. (2011) Blockade of gC1qR/p33, a receptor for C1q, inhibits adherence of Staphylococcus aureus to the microvascular endothelium. Microvascular Research 82:1, 66-72
CrossRef44
Varnika Roy, Bryn L. Adams, William E. Bentley. (2011) Developing next generation antimicrobials by intercepting AI-2 mediated quorum sensing. Enzyme and Microbial Technology 49:2, 113-123
CrossRef45
R. Nazareth, J. Gonçalves-Pereira, A. Tavares, M. Miragai, H. de Lencastre, J. Silvestre, P. Freitas, E. Gonçalves, F. Martins, V. Mendes, C. Tapadinhas, P. Póvoa. (2011) Community-associated methicillin-resistant Staphylococcus aureus infection in Portugal. Revista Portuguesa de Pneumologia
CrossRef46
D. Mithoe, M. I. A. Rijnders, B. M. Roede, E. Stobberingh, A. V. M. Möller. (2011) Prevalence of community-associated meticillin-resistant Staphylococcus aureus and Panton–Valentine leucocidin-positive S. aureus in general practice patients with skin and soft tissue infections in the northern and southern regions of The Netherlands. European Journal of Clinical Microbiology & Infectious Diseases
CrossRef47
Jeanette M. Daly, John W. Ely, Barcey T. Levy, Tara C. Smith, Mary L. Merchant, George R. Bergus, Gerald J. Jogerst. (2011) Primary Care Clinicians’ Perspectives on Management of Skin and Soft Tissue Infections: An Iowa Research Network Study. The Journal of Rural Health 27:3, 319-328
CrossRef48
Robertino M. Mera, Jose A. Suaya, Heather Amrine-Madsen, Cosmina S. Hogea, Linda A. Miller, Emily P. Lu, Daniel F. Sahm, Patrick O'Hara, Camilo J. Acosta. (2011) Increasing Role of Staphylococcus aureus and Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in the United States: A 10-Year Trend of Replacement and Expansion. Microbial Drug Resistance 17:2, 321-328
CrossRef49
Shu-Hui Tseng, Chun-Ming Lee, Tzou-Yien Lin, Shan-Chwen Chang, Feng-Yee Chang. (2011) Emergence and spread of multi-drug resistant organisms: Think globally and act locally. Journal of Microbiology, Immunology and Infection 44:3, 157-165
CrossRef50
Ronan K. Carroll, Samuel A. Shelburne, Randall J. Olsen, Bryce Suber, Pranoti Sahasrabhojane, Muthiah Kumaraswami, Stephen B. Beres, Patrick R. Shea, Anthony R. Flores, James M. Musser. (2011) Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice. Journal of Clinical Investigation 121:5, 1956-1968
CrossRef51
(2011) Combating Antimicrobial Resistance: Policy Recommendations to Save Lives. Clinical Infectious Diseases 52:Supplement 5, S397-S428
CrossRef52
Ioannis G. Baraboutis. (2011) Metastatic Staphylococcus aureus Bloodstream Infections. Southern Medical Journal 104:5, 305-306
CrossRef53
Romolo J. Gaspari, Dana Resop, Michelle Mendoza, Tarina Kang, David Blehar. (2011) A Randomized Controlled Trial of Incision and Drainage Versus Ultrasonographically Guided Needle Aspiration for Skin Abscesses and the Effect of Methicillin-Resistant Staphylococcus aureus. Annals of Emergency Medicine 57:5, 483-491.e1
CrossRef54
Lynn N. Fitzgibbons, Darcy L. Puls, Kimberly Mackay, Graeme N. Forrest. (2011) Management of Gram-Positive Coccal Bacteremia and Hemodialysis. American Journal of Kidney Diseases 57:4, 624-640
CrossRef55
S. Y. Park, J. S. Son, I. H. Oh, J. M. Choi, M. S. Lee. (2011) Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores. Infection 39:2, 141-147
CrossRef56
Tobias Hirsch, Simin Limoochi-Deli, Armin Lahmer, Frank Jacobsen, Ole Goertz, Hans-Ulrich Steinau, Hans-Martin Seipp, Lars Steinstraesser. (2011) Antimicrobial Activity of Clinically Used Antiseptics and Wound Irrigating Agents in Combination with Wound Dressings. Plastic and Reconstructive Surgery 127:4, 1539-1545
CrossRef57
Mario E. Arena, Elena Cartagena, Nadia Gobbato, Mario Baigori, Juan C. Valdez, Alicia Bardon. (2011) In vivo and in vitro antibacterial activity of acanthospermal B, a sesquiterpene lactone isolated from Acanthospermum hispidum. Phytotherapy Research 25:4, 597-602
CrossRef58
J. A. Ramirez, A. R. Anzueto. (2011) Changing needs of community-acquired pneumonia. Journal of Antimicrobial Chemotherapy 66:Supplement 3, iii3-iii9
CrossRef59
Nina Kaur Hansra, Kanade Shinkai. (2011) Cutaneous community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus. Dermatologic Therapy 24:2, 263-272
CrossRef60
K. J. COMO-SABETTI, K. H. HARRIMAN, S. K. FRIDKIN, S. L. JAWAHIR, R. LYNFIELD. (2011) Risk factors for community-associated Staphylococcus aureus infections: results from parallel studies including methicillin-resistant and methicillin-sensitive S. aureus compared to uninfected controls. Epidemiology and Infection 139:03, 419-429
CrossRef61
C. L. Snyder. (2011) Hospitalizations for CA-MRSA Soft Tissue Infection. AAP Grand Rounds 25:2, 20-20
CrossRef62
C. Liu, A. Bayer, S. E. Cosgrove, R. S. Daum, S. K. Fridkin, R. J. Gorwitz, S. L. Kaplan, A. W. Karchmer, D. P. Levine, B. E. Murray, M. J. Rybak, D. A. Talan, H. F. Chambers. (2011) Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children. Clinical Infectious Diseases 52:3, e18-e55
CrossRef63
Ashley L. DuMont, Tyler K. Nygaard, Robert L. Watkins, Amanda Smith, Lina Kozhaya, Barry N. Kreiswirth, Bo Shopsin, Derya Unutmaz, Jovanka M. Voyich, Victor J. Torres. (2011) Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Molecular Microbiology 79:3, 814-825
CrossRef64
Hernando R. Perez, Rachel Johnson, Patrick L. Gurian, Shawn G. Gibbs, Jennifer Taylor, Igor Burstyn. (2011) Isolation of Airborne Oxacillin-Resistant Staphylococcus aureus from Culturable Air Samples of Urban Residences. Journal of Occupational and Environmental Hygiene 8:2, 80-85
CrossRef65
Ian M Overton, Shirley Graham, Katherine A Gould, Jason Hinds, Catherine H Botting, Sally Shirran, Geoffrey J Barton, Peter J Coote. (2011) Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus. BMC Systems Biology 5:1, 68
CrossRef66
Barbara E. Barnes, Deborah A. Sampson. (2011) A literature review on community-acquired methicillin-resistant Staphylococcus aureus in the United States: Clinical information for primary care nurse practitioners. Journal of the American Academy of Nurse Practitioners 23:1, 23-32
CrossRef67
D. Wu, X. Li, Y. Yang, Y. Zheng, C. Wang, L. Deng, L. Liu, C. Li, Y. Shang, C. Zhao, S. Yu, X. Shen. (2011) Superantigen gene profiles and presence of exfoliative toxin genes in community-acquired meticillin-resistant Staphylococcus aureus isolated from Chinese children. Journal of Medical Microbiology 60:1, 35-45
CrossRef68
Rakesh D. Mistry, Halden F. Scott, Theoklis E. Zaoutis, Elizabeth R. Alpern. (2011) Emergency Department Treatment Failures for Skin Infections in the Era of Community-Acquired Methicillin-Resistant Staphylococcus aureus. Pediatric Emergency Care 27:1, 21-26
CrossRef69
Martin Desrosiers, Gerald A Evans, Paul K Keith, Erin D Wright, Alan Kaplan, Jacques Bouchard, Anthony Ciavarella, Patrick W Doyle, Amin R Javer, Eric S Leith, Atreyi Mukherji, R Robert Schellenberg, Peter Small, Ian J Witterick. (2011) Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy, Asthma & Clinical Immunology 7:1, 2
CrossRef70
Na-Young Shin, Jin-Hong Yoo, Chulmin Park, Dong-Gun Lee, Su-Mi Choi, Jae-Cheol Kwon, Si-Hyun Kim, Sun-Hee Park, Jung-Hyun Choi. (2011) Application of Infrequent-Restriction-Site Polymerase Reaction (IRS-PCR) to the Molecular Epidemiologic Analysis of Methicillin Resistant Staphylococcus aureus (MRSA). Infection and Chemotherapy 43:5, 396
CrossRef71
Hitoshi Iwabuchi, Tokuya Nakahara, Machiko Okamoto, Manabu Asano, Kenichi Oguchi, Kiyoshi Kurokawa, Hachiro Yamanishi, Kazuhiro Tateda, Keizo Yamaguchi. (2011) Sepsis in hemodialysis patients. Nihon Toseki Igakkai Zasshi 44:7, 617-622
CrossRef72
Jon P Furuno, Jennifer K Johnson, Marin L Schweizer, Anayochukwu Uche, Oscar C Stine, Simone M Shurland, Graeme N Forrest. (2011) Community-associated Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis among HIV Patients: A cohort study. BMC Infectious Diseases 11:1, 298
CrossRef73
Hidenobu Kawabata, Manabu Murakami, Kengo Kisa, Masaji Maezawa. (2011) Incidence of Community-associated Methicillin-resistant Staphylococcus aureus Infections in a Regional Hospital. Journal of Rural Medicine 6:1, 22-25
CrossRef74
Harvey W. Meislin, Megan A. Meislin. 2011. Soft-tissue infections. , 331-338.
CrossRef75
Chih-Hsuan Changchien, Ying-Ying Chen, Shu-Wun Chen, Wan-Lin Chen, Jwu-Guh Tsay, Chishih Chu. (2011) Retrospective study of necrotizing fasciitis and characterization of its associated Methicillin-resistant Staphylococcus aureus in Taiwan. BMC Infectious Diseases 11:1, 297
CrossRef76
Michelle Pepper, Stuart Willick, Timothy Beals, R. Lor Randall. (2010) An Unusual Cause of Heel Pain in a Young Athlete: A Case Report. PM&R 2:12, 1145-1148
CrossRef77
Guliz Erdem, Lora Bergert, Kyra Len, Marian Melish, Kevin Kon, Robert DiMauro. (2010) Radiological findings of community-acquired methicillin-resistant and methicillin-susceptible Staphylococcus aureus pediatric pneumonia in Hawaii. Pediatric Radiology 40:11, 1768-1773
CrossRef78
Dilip Nathwani, Lynn Urquhart. (2010) Community-Acquired Methicillin-Resistant Staphylococcus aureus Pneumonia. Clinical Pulmonary Medicine 17:6, 260-265
CrossRef79
Christopher R. Frei, Monica L. Miller, James S. Lewis, Kenneth A. Lawson, Rajesh Peddaiahgari, Robert L. Talbert. (2010) Retrospective cohort study of hospitalized adults treated with vancomycin or clindamycin for methicillin-resistant Staphylococcus aureus skin infections. Clinical Therapeutics 32:12, 2024-2029
CrossRef80
S. Gatermann, I.F. Chaberny, M. Pletz, B. Schaaf. (2010) Multiresistente pulmonale Erreger auf der Intensivstation. Der Pneumologe 7:6, 412-422
CrossRef81
Huda A. Bukharie. (2010) Increasing Threat of Community-Acquired Methicillin-Resistant Staphylococcus aureus. The American Journal of the Medical Sciences 340:5, 378-381
CrossRef82
L. J. Shallcross, K. Williams, S. Hopkins, R. W. Aldridge, A. M. Johnson, A. C. Hayward. (2010) Panton-Valentine leukocidin associated staphylococcal disease: a cross-sectional study at a London hospital, England. Clinical Microbiology and Infection 16:11, 1644-1648
CrossRef83
Michael Otto. (2010) Basis of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus *. Annual Review of Microbiology 64:1, 143-162
CrossRef84
Lei Zhang, Fei Ye, Yan He, Dan Kong, Changsong Han, Zhijie Zhao, Jiang Zhu, Hongxue Meng, Xinghan Liu, Xiaoming Jin. (2010) Establishment of a Mouse IgA Nephropathy Model With the MBP-20-Peptide Fusion Protein. The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 293:10, 1729-1737
CrossRef85
Ahmed F Elsahn, Elvin H Yildiz, Donald L Jungkind, Yasmine F Abdalla, Mesut Erdurmus, Federico A Cremona, Christopher J Rapuano, Kristin M Hammersmith, Elisabeth J Cohen. (2010) In Vitro Susceptibility Patterns of Methicillin-Resistant Staphylococcus aureus and Coagulase-Negative Staphylococcus Corneal Isolates to Antibiotics. Cornea 29:10, 1131-1135
CrossRef86
S.-H. Wang, Z.-L. Sun, Y.-J. Guo, B.-Q. Yang, Y. Yuan, Q. Wei, K.-P. Ye. (2010) Meticillin-resistant Staphylococcus aureus isolated from foot ulcers in diabetic patients in a Chinese care hospital: risk factors for infection and prevalence. Journal of Medical Microbiology 59:10, 1219-1224
CrossRef87
Natalie L. McCarthy, Patrick S. Sullivan, Robert Gaynes, David Rimland. (2010) Health care-associated and community-associated methicillin-resistant Staphylococcus aureus infections: A comparison of definitions. American Journal of Infection Control 38:8, 600-606
CrossRef88
Robin A. Pollini, Manuel Gallardo, Samreen Hasan, Joshua Minuto, Remedios Lozada, Alicia Vera, María Luisa Zúñiga, Steffanie A. Strathdee. (2010) High prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico. International Journal of Infectious Diseases 14, e117-e122
CrossRef89
D. M. Sievert, M. L. Wilson, M. J. Wilkins, B. W. Gillespie, M. L. Boulton. (2010) Public Health Surveillance for Methicillin-Resistant Staphylococcus aureus: Comparison of Methods for Classifying Health Care- and Community-Associated Infections. American Journal of Public Health 100:9, 1777-1783
CrossRef90
Kyra A. Len, Lora Bergert, Shilpa Patel, Marian Melish, Chieko Kimata, Guliz Erdem. (2010) Community-acquired Staphylococcus aureus pneumonia among hospitalized children in Hawaii. Pediatric Pulmonology 45:9, 898-905
CrossRef91
Jae-Hoon Song, Doo Ryeon Chung. (2010) Respiratory Infections Due to Drug-Resistant Bacteria. Infectious Disease Clinics of North America 24:3, 639-653
CrossRef92
Jeffry L. Kashuk, Ernest E. Moore, Connie S. Price, Christopher Zaw-Mon, Theresa Nino, James Haenel, Walter L. Biffl, C. Cothren Burlew, Jeffrey L. Johnson. (2010) Patterns of Early and Late Ventilator-Associated Pneumonia Due to Methicillin-Resistant Staphylococcus aureus in a Trauma Population. The Journal of Trauma: Injury, Infection, and Critical Care 69:3, 519-522
CrossRef93
Shareef Jandali, Marija Ugrinich, Benjamin Chang. (2010) Looped Penrose Drain for Minimally Invasive Treatment of Complex Superficial Abscesses of the Hand. HAND 5:3, 338-340
CrossRef94
Daniel Curcio. (2010) Resistant pathogen-associated skin and skin-structure infections: antibiotic options. Expert Review of Anti-infective Therapy 8:9, 1019-1036
CrossRef95
K. J. Travers, C.-S. Chin, D. R. Rank, J. S. Eid, S. W. Turner. (2010) A flexible and efficient template format for circular consensus sequencing and SNP detection. Nucleic Acids Research 38:15, e159-e159
CrossRef96
Sarada S. Panchanathan, Diana B. Petitti, Douglas B. Fridsma. (2010) The development and validation of a simulation tool for health policy decision making. Journal of Biomedical Informatics 43:4, 602-607
CrossRef97
M. C. Wehrhahn, J. O. Robinson, J. C. Pearson, F. G. O’Brien, H. L. Tan, G. W. Coombs, E. M. Pascoe, R. Lee, P. Salvaris, R. Salvaris, D. New, R. J. Murray. (2010) Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case–control study. European Journal of Clinical Microbiology & Infectious Diseases 29:8, 1025-1033
CrossRef98
Paulina Nastaly, Mariusz Grinholc, Krzysztof P. Bielawski. (2010) Molecular characteristics of community-associated methicillin-resistant Staphylococcus aureus strains for clinical medicine. Archives of Microbiology 192:8, 603-617
CrossRef99
Clive S. Cockram, Nelson Lee. 2010. Diabetes and Infections. , 835-855.
CrossRef100
Francisco López-Medrano, José María Aguado. (2010) Staphylococcus aureus con sensibilidad disminuida a vancomicina. Nuevos problemas para el clínico. Medicina Clínica 135:4, 160-161
CrossRef101
Natasha Atanaskova, Kenneth J. Tomecki. (2010) Innovative Management of Recurrent Furunculosis. Dermatologic Clinics 28:3, 479-487
CrossRef102
Steven M. Zinder, Rodney S. W. Basler, Jack Foley, Chris Scarlata, David B. Vasily. (2010) National Athletic Trainers' Association Position Statement: Skin Diseases. Journal of Athletic Training 45:4, 411-428
CrossRef103
F. J. Cooke, N. M. Brown. (2010) Community-associated methicillin-resistant Staphylococcus aureus infections. British Medical Bulletin 94:1, 215-227
CrossRef104
Erin A. Chuck, Bradley W. Frazee, Larry Lambert, Robert McCabe. (2010) The Benefit of Empiric Treatment for Methicillin-Resistant Staphylococcus Aureus. The Journal of Emergency Medicine 38:5, 567-571
CrossRef105
Roy F. Chemaly, Ray Y. Hachem, Rola N. Husni, Boulos Bahna, Georges Abou Rjaili, Alain Waked, Linda Graviss, B. Nebiyou Bekele, Jharna N. Shah, Issam I. Raad. (2010) Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Surgical-Site Infections in Patients with Cancer: a Case–Control Study. Annals of Surgical Oncology 17:6, 1499-1506
CrossRef106
Alex G. Ortega-Loayza, Stephanie A. Diamantis, Peter Gilligan, Dean S. Morrell. (2010) Characterization of Staphylococcus aureus cutaneous infections in a pediatric dermatology tertiary health care outpatient facility. Journal of the American Academy of Dermatology 62:5, 804-811
CrossRef107
B. A. Lipsky, Y. P. Tabak, R. S. Johannes, L. Vo, L. Hyde, J. A. Weigelt. (2010) Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia 53:5, 914-923
CrossRef108
A. J. KALLEN, C. REED, M. PATTON, K. E. ARNOLD, L. FINELLI, J. HAGEMAN. (2010) Staphylococcus aureus community-onset pneumonia in patients admitted to children's hospitals during autumn and winter of 2006–2007. Epidemiology and Infection 138:05, 666
CrossRef109
Frank R DeLeo, Michael Otto, Barry N Kreiswirth, Henry F Chambers. (2010) Community-associated meticillin-resistant Staphylococcus aureus. The Lancet 375:9725, 1557-1568
CrossRef110
Kara B. Mascitti, Jeffrey S. Gerber, Theoklis E. Zaoutis, Todd D. Barton, Ebbing Lautenbach. (2010) Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: A survey of adult and pediatric providers. American Journal of Infection Control 38:4, 324-328
CrossRef111
Bryan K. Monson, Jack Stringham, Brandt B. Jones, Salwa Abdel-Aziz, Carolee M. Cutler Peck, Randall J. Olson. (2010) Scanning Electron Microscopy Visualization of Methicillin-Resistant Staphylococcus aureus After Contact With Gatifloxacin With and Without Preservative. Journal of Ocular Pharmacology and Therapeutics 26:2, 133-136
CrossRef112
Randall J. Olsen, Scott D. Kobayashi, Ara A. Ayeras, Madiha Ashraf, Shawna F. Graves, Willie Ragasa, Tammy Humbird, Jamieson L. Greaver, Constance Cantu, Jody L. Swain, Leslie Jenkins, Terry Blasdel, Philip T. Cagle, Donald J. Gardner, Frank R. DeLeo, James M. Musser. (2010) Lack of a Major Role of Staphylococcus aureus Panton-Valentine Leukocidin in Lower Respiratory Tract Infection in Nonhuman Primates. The American Journal of Pathology 176:3, 1346-1354
CrossRef113
M. Dryden, A. T. Andrasevic, M. Bassetti, E. Bouza, J. Chastre, G. Cornaglia, S. Esposito, G. French, H. Giamarellou, I. C. Gyssens, D. Nathwani, S. Unal, A. Voss. (2010) A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice. Clinical Microbiology and Infection 16, 3-30
CrossRef114
Geoffrey C Nguyen, Harshna Patel, Rachel Y Chong. (2010) Increased Prevalence of and Associated Mortality With Methicillin-Resistant Staphylococcus aureus Among Hospitalized IBD Patients. The American Journal of Gastroenterology 105:2, 371-377
CrossRef115
Erin H Kil, Jeffrey M Weinberg. (2010) Methicillin-resistant Staphylococcus aureus : an update for the dermatologist. Expert Review of Dermatology 5:1, 45-60
CrossRef116
Rakesh D. Mistry, Keith Weisz, Halden F. Scott, Elizabeth R. Alpern. (2010) Emergency Management of Pediatric Skin and Soft Tissue Infections in the Community-associated Methicillin-resistant Staphylococcus aureus Era. Academic Emergency Medicine 17:2, 187-193
CrossRef117
Ilene Claudius, Larry J. Baraff. (2010) Pediatric Emergencies Associated with Fever. Emergency Medicine Clinics of North America 28:1, 67-84
CrossRef118
Jae-Hoon Song, Eun-Jeong Joo. (2010) The crisis of antimicrobial resistance: current status and future strategies. Journal of the Korean Medical Association 53:11, 999
CrossRef119
Sun Woo Kim, Dong-Gun Lee, Su-Mi Choi, Chulmin Park, Jae-Cheol Kwon, Si-Hyun Kim, Sun Hee Park, Jung-Hyun Choi, Jin-Hong Yoo, Wan-Shik Shin. (2010) Once-Daily Gentamicin Administration for Community-Associated Methicillin Resistant Staphylococcus aureus in an in vitro Pharmacodynamic Model: Preliminary Reports for the Advantages for Optimizing Pharmacodynamic Index. Yonsei Medical Journal 51:5, 722
CrossRef120
In-Gyu Bae, Jae Seok Kim, Sunjoo Kim, Sang Taek Heo, Chulhun Chang, Eun-Yup Lee. (2010) Genetic Correlation of Community-Associated Methicillin-Resistant Staphylococcus aureus Strains from Carriers and from Patients with Clinical Infection in One Region of Korea. Journal of Korean Medical Science 25:2, 197
CrossRef121
Matthew I. Peña, Elizabeth Van Itallie, Matthew R. Bennett, Yousif Shamoo. (2010) Evolution of a single gene highlights the complexity underlying molecular descriptions of fitness. Chaos: An Interdisciplinary Journal of Nonlinear Science 20:2, 026107
CrossRef122
Yao-Peng Hsieh, Yao-Ko Wen, Mei-Ling Chen. (2010) Comparison of Typical Endocapillary and Atypical Mesangial Proliferation in Postinfectious Glomerulonephritis. Renal Failure 32:1, 55-61
CrossRef123
Sharon Lewin. 2010. Gender Differences in Emerging Infectious Diseases. , 497-515.
CrossRef124
G Lorette, Ph Beaulieu, FA Allaert, A Mahmoudi, V Jarlier. (2009) Superficial community-acquired skin infections: prevalence of bacteria and antibiotic susceptibility in France. Journal of the European Academy of Dermatology and Venereology 23:12, 1423-1426
CrossRef125
W. Witte. (2009) Community-acquired methicillin-resistant Staphylococcus aureus : what do we need to know?. Clinical Microbiology and Infection 15, 17-25
CrossRef126
Stephanie A. Fritz, Emma K. Epplin, Jane Garbutt, Gregory A. Storch. (2009) Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus. Journal of Infection 59:6, 394-401
CrossRef127
Dirk M. Elston. (2009) Update on Cutaneous Manifestations of Infectious Diseases. Medical Clinics of North America 93:6, 1283-1290
CrossRef128
J. M. Talia, M. A. Alvarez, N. B. Debattista, N. B. Pappano. (2009) Susceptibility of Staphylococcus aureus strains toward combinations of oxacillin-2,4-dihydroxychalcone. Folia Microbiologica 54:6, 516-520
CrossRef129
A. Kohlenberg, F. Schwab, E. Meyer, M. Behnke, C. Geffers, P. Gastmeier. (2009) Regional trends in multidrug-resistant infections in German intensive care units: a real-time model for epidemiological monitoring and analysis. Journal of Hospital Infection 73:3, 239-245
CrossRef130
Anne Stone, Lynne Quittell, Juyan Zhou, Luis Alba, Meera Bhat, Joan DeCelie-Germana, Sujatha Rajan, Lynn Bonitz, John J. Welter, Allen J. Dozor, Ingrid Gherson, Franklin D. Lowy, Lisa Saiman. (2009) Staphylococcus aureus Nasal Colonization Among Pediatric Cystic Fibrosis Patients and Their Household Contacts. The Pediatric Infectious Disease Journal 28:10, 895-899
CrossRef131
David S. Paek, Milan Nadkarni, Manav Singla. (2009) Treatment of MRSA Infections in an African-American Male with G6PD Deficiency. The Journal of Emergency Medicine 37:3, 273-278
CrossRef132
Addison K. May, Renae E. Stafford, Eileen M. Bulger, Daithi Heffernan, Oscar Guillamondegui, Grant Bochicchio, Soumitra R. Eachempati. (2009) Treatment of Complicated Skin and Soft Tissue Infections. Surgical Infections 10:5, 467-499
CrossRef133
C Glen Mayhall. 2009. Methicillin-Resistant Staphylococcus aureus /Vancomycin-Resistant Enterococci Colonization and Infection in the Critical CareUnit. , 102-127.
CrossRef134
Ronald Pangilinan, Alan Tice, Glenn Tillotson. (2009) Topical antibiotic treatment for uncomplicated skin and skin structure infections: review of the literature. Expert Review of Anti-infective Therapy 7:8, 957-965
CrossRef135
Mamta Sharma, Louis D. Saravolatz. 2009. Severe Skin and Soft Tissue Infections inCritical Care. , 295-321.
CrossRef136
J.W.T. Elston, G.D. Barlow. (2009) Community-associated MRSA in the United Kingdom. Journal of Infection 59:3, 149-155
CrossRef137
Lena M. Napolitano. (2009) Severe Soft Tissue Infections. Infectious Disease Clinics of North America 23:3, 571-591
CrossRef138
Henry F. Chambers, Frank R. DeLeo. (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature Reviews Microbiology 7:9, 629-641
CrossRef139
Rachel Albalak. (2009) From biological anthropology to applied public health: Epidemiological approaches to the study of infectious disease. American Journal of Human Biology 21:5, 687-693
CrossRef140
Dennis L. Stevens. (2009) Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria. Journal of Infection 59, S32-S39
CrossRef141
Dilip Nathwani. (2009) Health economic issues in the treatment of drug-resistant serious Gram-positive infections. Journal of Infection 59, S40-S50
CrossRef142
I. M. GOULD, E. K. GIRVAN, R. A. BROWNING, F. M. MACKENZIE, G. F. S. EDWARDS. (2009) Report of a hospital neonatal unit outbreak of community-associated methicillin-resistant Staphylococcus aureus. Epidemiology and Infection 137:09, 1242
CrossRef143
Frank R. DeLeo, Henry F. Chambers. (2009) Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. Journal of Clinical Investigation 119:9, 2464-2474
CrossRef144
S. MALIK, P. VRANKEN, M. SILIO, R. RATARD, R. VAN DYKE. (2009) Prevalence of community-associated methicillin-resistant Staphylococcus aureus colonization outside the healthcare environment. Epidemiology and Infection 137:09, 1237
CrossRef145
Ioannis G. Baraboutis, Maria Koukoulaki, Helen Belesiotou, Evaggelia Platsouka, Vassilios Papastamopoulos, Dimitrios Kontothanasis, Katerina Kontogianni-Katsarou, Eleftheria P. Tsagalou, Olga Paniara, Athanasios T. Skoutelis. (2009) Community-Acquired Methicillin-Resistant Staphylococcus aureus as a Cause of Rapidly Progressing Pyelonephritis With Pyonephrosis, Necessitating Emergent Nephrectomy. The American Journal of the Medical Sciences 338:3, 233-235
CrossRef146
J.W.T. Elston, J. Meigh, A.M. Kearns, N. Jordan-Owers, A. Newton, R.E. Meigh, G. Barlow. (2009) Community-associated meticillin-resistant Staphylococcus aureus: epidemiology, microbiology and clinical impact in East Yorkshire, UK. Journal of Hospital Infection 72:4, 307-313
CrossRef147
Carol L. Moore, Ameet Hingwe, Susan M. Donabedian, Mary B. Perri, Susan L. Davis, Nadia Z. Haque, Katherine Reyes, Dora Vager, Marcus J. Zervos. (2009) Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections. International Journal of Antimicrobial Agents 34:2, 148-155
CrossRef148
Rakesh D. Mistry, Sandra H. Schwab, James R. Treat. (2009) Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Pediatric Emergency Care 25:8, 519-522
CrossRef149
Agnès Roux, Shelley M. Payne, Michael S. Gilmore. (2009) Microbial Telesensing: Probing the Environment for Friends, Foes, and Food. Cell Host & Microbe 6:2, 115-124
CrossRef150
Rishi Dhillon, John Clark. (2009) Infection in the intensive care unit (ICU). Current Anaesthesia & Critical Care 20:4, 175-182
CrossRef151
Serhat Unal. (2009) Treatment options for skin and soft tissue infections: ‘oldies but goldies’. International Journal of Antimicrobial Agents 34, S20-S23
CrossRef152
Beth L. Hahn, Charles C. Onunkwo, Christopher J. Watts, Peter G. Sohnle. (2009) Systemic dissemination and cutaneous damage in a mouse model of staphylococcal skin infections. Microbial Pathogenesis 47:1, 16-23
CrossRef153
Carrie Reed, Alexander J. Kallen, Monica Patton, Kathryn E. Arnold, Monica M. Farley, Jeff Hageman, Lyn Finelli. (2009) Infection With Community-Onset Staphylococcus aureus and Influenza Virus in Hospitalized Children. The Pediatric Infectious Disease Journal 28:7, 572-576
CrossRef154
Timothy A Tolbert, Helen M Binkley. (2009) Prevention of Community-Associated Methicillin-Resistant Staphylococcus Aureus in the Athletic Environment. Strength and Conditioning Journal 31:3, 85-90
CrossRef155
D.A. Enoch, J.A. Karas, S.H. Aliyu. (2009) Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by meticillin-resistant Staphylococcus aureus (MRSA) in the UK. International Journal of Antimicrobial Agents 33:6, 497-502
CrossRef156
Alicia I Hidron, Cari E Low, Eric G Honig, Henry M Blumberg. (2009) Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. The Lancet Infectious Diseases 9:6, 384-392
CrossRef157
Joachim Dissemond. (2009) Methicillin resistant Staphylococcus aureus (MRSA): Diagnostic, clinical relevance and therapy. Journal der Deutschen Dermatologischen Gesellschaft 7:6, 544-553
CrossRef158
Kamal M.F. Itani, Kasem S. Akhras, Robert Stellhorn, Alvaro Quintana, David Budd, Sanjay Merchant. (2009) Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections. PharmacoEconomics 27:5, 421-430
CrossRef159
S. Burgassi, I. Zanardi, V. Travagli, E. Montomoli, V. Bocci. (2009) How much ozone bactericidal activity is compromised by plasma components?. Journal of Applied Microbiology 106:5, 1715-1721
CrossRef160
Addison K. May. (2009) Skin and Soft Tissue Infections. Surgical Clinics of North America 89:2, 403-420
CrossRef161
Sheree MS Smith. (2009) A review of hand-washing techniques in primary care and community settings. Journal of Clinical Nursing 18:6, 786-790
CrossRef162
Loren G. Miller, Sheldon L. Kaplan. (2009) Staphylococcus aureus: A Community Pathogen. Infectious Disease Clinics of North America 23:1, 35-52
CrossRef163
Henry R. Shinefield, Naomi L. Ruff. (2009) Staphylococcal Infections: A Historical Perspective. Infectious Disease Clinics of North America 23:1, 1-15
CrossRef164
Adam D. Kennedy, Frank R. DeLeo. (2009) Neutrophil apoptosis and the resolution of infection. Immunologic Research 43:1-3, 25-61
CrossRef165
Mark D. Ebert, Sheila Sheth, Elliot K. Fishman. (2009) Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of “mayhem in the lung”. Emergency Radiology 16:2, 159-162
CrossRef166
Helio S. Sader, Thomas R. Fritsche, Ronald N. Jones. (2009) Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients. International Journal of Infectious Diseases 13:2, 291-295
CrossRef167
Sun Hee Park, Chulmin Park, Jin‐Hong Yoo, Su‐Mi Choi, Jung‐Hyun Choi, Hyun‐Ho Shin, Dong‐Gun Lee, Seungok Lee, JaYoung Kim, So Eun Choi, Young‐Mi Kwon, Wan‐Shik Shin. (2009) Emergence of Community‐Associated Methicillin‐Resistant Staphylococcus aureus Strains as a Cause of Healthcare‐Associated Bloodstream Infections in Korea. Infection Control and Hospital Epidemiology 30:2, 146-155
CrossRef168
Michael P. Stevens, Michael B. Edmond. (2009) The Rising Tide: Skin and Soft Tissue Infections Due to Community-Associated Methicillin-Resistant Staphylococcus aureus. Southern Medical Journal 102:2, 121-122
CrossRef169
Dimitri M. Drekonja, Laura M. Traynor, Douglas D. DeCarolis, Kent B. Crossley, James R. Johnson. (2009) Treatment of non–life-threatening methicillin-resistant Staphylococcus aureus infections with alternative antimicrobial agents: a 2-year retrospective review. Diagnostic Microbiology and Infectious Disease 63:2, 201-207
CrossRef170
Elizabeth Tejeda-Ramirez, Majda Behani, Robert J. Leggiadro. (2009) Community-Associated Methicillin-Resistant Staphylococcal Infection in an Inner City Hospital Pediatric Inpatient Population. Southern Medical Journal 102:2, 135-138
CrossRef171
Nelson P. Nicolasora, Mark A. Zacharek, Anurag N. Malani. (2009) Community-Acquired Methicillin-Resistant Staphylococcus aureus: An Emerging Cause of Acute Bacterial Parotitis. Southern Medical Journal 102:2, 208-210
CrossRef172
Paula M. Vidal, Priscila A. Trindade, Tamara O. Garcia, Renata L. Pacheco, Silvia F. Costa, Cristina Reinert, Keiichi Hiramatsu, Elsa M. Mamizuka, Cilmara P. Garcia, Anna S. Levin. (2009) Differences Between “Classical” Risk Factors for Infections Caused by Methicillin‐Resistant Staphylococcus aureus (MRSA) and Risk Factors for Nosocomial Bloodstream Infections Caused by Multiple Clones of the Staphylococcal Cassette Chromosome mec Type IV MRSA Strain. Infection Control and Hospital Epidemiology 30:2, 139-145
CrossRef173
Hiroyuki HAYASHI, Takashi MATSUZAKI, Yasuko MIZUNO, Masahiro KAWAI, Taketo IWAHORI, Akio SAITO, Takahiko AOYAMA, Yoshiaki MATSUMOTO. (2009) Analysis of Factors Affecting Long-term Administration of anti-Methicillin Resistant Staphylococcus aureus (MRSA) Drugs. YAKUGAKU ZASSHI 129:3, 347-352
CrossRef174
A. J. HALL, D. BIXLER, L. E. HADDY. (2009) Multiclonal outbreak of methicillin-resistant Staphylococcus aureus infections on a collegiate football team. Epidemiology and Infection 137:01, 85
CrossRef175
Dirk M. Elston. (2009) How to Handle a CA-MRSA Outbreak. Dermatologic Clinics 27:1, 43-48
CrossRef176
S. J. van Hal, Z. Jennings, D. Stark, D. Marriott, J. Harkness. (2009) MRSA detection: comparison of two molecular methods (BD GeneOhm® PCR assay and Easy-Plex) with two selective MRSA agars (MRSA-ID and Oxoid MRSA) for nasal swabs. European Journal of Clinical Microbiology & Infectious Diseases 28:1, 47-53
CrossRef177
Mukesh Patel. (2009) Community-Associated Meticillin-Resistant Staphylococcus aureus Infections. Drugs 69:6, 693-716
CrossRef178
Helen Van Hoecke, Anne Piette, Els De Leenheer, Nathalie Lagasse, Marc Struelens, Gerda Verschraegen, Ingeboy Dhooge. (2009) Destructive otomastoiditis by MRSA from porcine origin. The Laryngoscope 119:1, 137-140
CrossRef179
J.V. Hirschmann. (2009) When Antibiotics are Unnecessary. Dermatologic Clinics 27:1, 75-83
CrossRef180
Sharon Kleinschmidt, Christopher Lidstone, Belinda Henderson, Joan Faoagali. (2009) Comparison of the BD GeneOhm MRSA assay, broth enrichment culture and chromID MRSA for detection of methicillin-resistant Staphylococcus aureus from inter-hospital intensive care transfer patients. Healthcare Infection 14:3, 89
CrossRef181
Carlos Cervera, Manel Almela, José A. Martínez-Martínez, Asunción Moreno, José M. Miró. (2009) Risk factors and management of Gram-positive bacteraemia. International Journal of Antimicrobial Agents 34, S26-S30
CrossRef182
Yao-Ko Wen. (2009) The Spectrum of Adult Postinfectious Glomerulonephritis in the New Millennium. Renal Failure 31:8, 676-682
CrossRef183
Renee M. Brennan-Calanan, Mark A. Gallo. (2008) Bacterial air pollution at a wastewater treatment plant. BIOS 79:4, 150-159
CrossRef184
Timothy J. Whitman. (2008) Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections. Disease-a-Month 54:12, 780-786
CrossRef185
Benito Almirante, Juan de Dios Colmenero, Jesús Fortún, José Antonio Oteo, Juan Mari Santamaría, Julio Sola. (2008) La asistencia infectológica actual en España. Enfermedades Infecciosas y Microbiología Clínica 26, 23-32
CrossRef186
Mark D. Johnson, Catherine F. Decker. (2008) Antimicrobial Agents in Treatment of MRSA Infections. Disease-a-Month 54:12, 793-800
CrossRef187
Christopher Lee. (2008) Therapeutic challenges in the era of antibiotic resistance. International Journal of Antimicrobial Agents 32, S197-S199
CrossRef188
Yu-Hsiang Hsieh, Richard E Rothman, John G Bartlett, Samual Yang, Gabor D Kelen. (2008) HIV Seropositivity Predicts Longer Duration of Stay and Rehospitalization Among Nonbacteremic Febrile Injection Drug Users With Skin and Soft Tissue Infections. JAIDS Journal of Acquired Immune Deficiency Syndromes 49:4, 398-405
CrossRef189
Somvadee Laohavaleeson, Steven L Barriere, David P Nicolau, Joseph L Kuti. (2008) Cost-Effectiveness of Telavancin versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections. Pharmacotherapy 28:12, 1471-1482
CrossRef190
David K. Byers, Catherine F. Decker. (2008) The Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus. Disease-a-Month 54:12, 756-762
CrossRef191
Pramodini Kale-Pradhan, Leonard B Johnson. (2008) Treatment and recurrence management of staphylococcal infections: community-acquired MRSA. Expert Review of Anti-infective Therapy 6:6, 909-915
CrossRef192
Blaise R. Boles, Alexander R. Horswill. 2008. The Cyclization of Peptides and Proteins with Inteins. , 391-407.
CrossRef193
Uta Jappe, Dagmar Heuck, Birgit Strommenger, Constanze Wendt, Guido Werner, Doris Altmann, Wolfgang Witte. (2008) Staphylococcus aureus in Dermatology Outpatients with Special Emphasis on Community-Associated Methicillin-Resistant Strains. Journal of Investigative Dermatology 128:11, 2655-2664
CrossRef194
Kishore Yalamanchili, Jihad El Hayek, Pradeep Gujja. (2008) Methicillin-Resistant Staphylococcus aureus Nontropical Pyomyositis Leading to Empyema Thoracis. Infectious Diseases in Clinical Practice 16:6, 403-404
CrossRef195
R. A. Seaton. (2008) Daptomycin: rationale and role in the management of skin and soft tissue infections. Journal of Antimicrobial Chemotherapy 62:Supplement 3, iii15-iii23
CrossRef196
Stephan J. Landis. (2008) Chronic Wound Infection and Antimicrobial Use. Advances in Skin & Wound Care 21:11, 531-540
CrossRef197
Natasha VDV Ratnaraja, Peter M Hawkey. (2008) Current challenges in treating MRSA: what are the options?. Expert Review of Anti-infective Therapy 6:5, 601-618
CrossRef198
Irena Bakunas-Kenneley. (2008) Community-Acquired MRSA in Neonates: Prevention and Control in the Clinical Setting. Nursing for Women's Health 12:5, 396-402
CrossRef199
Randall G. Fisher, Rebecca L. Chain, Pamela S. Hair, Kenji M. Cunnion. (2008) HYPOCHLORITE KILLING OF COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS. The Pediatric Infectious Disease Journal 27:10, 934-935
CrossRef200
Matthew Dryden. (2008) Complicated Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus : Epidemiology, Risk Factors, and Presentation. Surgical Infections 9:s1, s3-s10
CrossRef201
Marin H. Kollef, Lena M. Napolitano, Joseph S. Solomkin, Richard G. Wunderink, In‐Gyu Bae, Vance G. Fowler, Robert A. Balk, Dennis L. Stevens, James J. Rahal, Andrew F. Shorr, Peter K. Linden, Scott T. Micek. (2008) Health Care–Associated Infection (HAI): A Critical Appraisal of the Emerging Threat—Proceedings of the HAI Summit. Clinical Infectious Diseases 47:s2, S55-S99
CrossRef202
Lena M. Napolitano. (2008) Early Appropriate Parenteral Antimicrobial Treatment of Complicated Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus. Surgical Infections 9:s1, s17-s27
CrossRef203
Sheldon L. Kaplan. (2008) COMMENTARY: PREVENTION OF RECURRENT STAPHYLOCOCCAL INFECTIONS. The Pediatric Infectious Disease Journal 27:10, 935-937
CrossRef204
Rachel J. Gorwitz. (2008) Community-Associated Methicillin-Resistant Staphylococcus aureus. The Pediatric Infectious Disease Journal 27:10, 925-926
CrossRef205
D Heath Stacey, Barry C. Fox, Samuel O. Poore, Michael L. Bentz, Karol A. Gutowski. (2008) Community-Acquired Methicillin-Resistant Staphylococcus aureus: Diagnosis and Treatment Update for Plastic Surgeons. Plastic and Reconstructive Surgery 122:4, 120e-127e
CrossRef206
Robert G. Sawyer. (2008) Detection and Initial Management of Complicated Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus. Surgical Infections 9:s1, s11-s15
CrossRef207
S. J. Rehm, H. Boucher, D. Levine, M. Campion, B. I. Eisenstein, G. A. Vigliani, G.R. Corey, E. Abrutyn. (2008) Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates. Journal of Antimicrobial Chemotherapy 62:6, 1413-1421
CrossRef208
S. N. Leonard, G. W. Kaatz, L. R. Rucker, M. J. Rybak. (2008) Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 62:6, 1305-1310
CrossRef209
(2008) Management of Skin and Soft-Tissue Infection. New England Journal of Medicine 359:10, 1063-1067
Full Text210
Kyle J. Popovich, Bala Hota, Robert A. Weinstein. (2008) Treatment of community-associated methicillin-resistant Staphylococcus aureus. Current Infectious Disease Reports 10:5, 411-420
CrossRef211
Michael James, Elizabeth A. Martinez. (2008) Antibiotics and perioperative infections. Best Practice & Research Clinical Anaesthesiology 22:3, 571-584
CrossRef212
Lucy A. Wibbenmeyer, Gerald P. Kealey, Barbara A. Latenser, Daniel J. Diekema, Ingrid M. Williams, Stacy L. Coffman, Patricia L. Winokur, Jennifer S. Kroeger, Robert W. Lewis, Loreen A. Herwaldt. (2008) Emergence of the USA300 Strain of Methicillin-Resistant Staphylococcus aureus in a Burn-Trauma Unit. Journal of Burn Care & Research 29:5, 790-797
CrossRef213
Andrea Ries Thurman, Tiffany M. Satterfield, David E. Soper. (2008) Methicillin-Resistant Staphylococcus aureus as a Common Cause of Vulvar Abscesses. Obstetrics & Gynecology 112:3, 538-544
CrossRef214
Andrew F. Shorr, Scott T. Micek, Marin H. Kollef. (2008) Inappropriate therapy for methicillin-resistant Staphylococcus aureus: Resource utilization and cost implications*. Critical Care Medicine 36:8, 2335-2340
CrossRef215
Rupak Datta, Susan S. Huang. (2008) Risk of Infection and Death due to Methicillin‐Resistant Staphylococcus aureus in Long‐Term Carriers. Clinical Infectious Diseases 47:2, 176-181
CrossRef216
M. V. BOOST, M. M. O'DONOGHUE, A. JAMES. (2008) Prevalence of Staphylococcus aureus carriage among dogs and their owners. Epidemiology and Infection 136:07,
CrossRef217
Jesús Saavedra-Lozano, Asunción Mejías, Naveed Ahmad, Estrella Peromingo, Monica I. Ardura, Sara Guillen, Ali Syed, Dominick Cavuoti, Octavio Ramilo. (2008) Changing Trends in Acute Osteomyelitis in Children. Journal of Pediatric Orthopaedics 28:5, 569-575
CrossRef218
Kevin O. Kisich, Charles W. Carspecken, Stephanie Fiéve, Mark Boguniewicz, Donald Y.M. Leung. (2008) Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human β-defensin-3. Journal of Allergy and Clinical Immunology 122:1, 62-68
CrossRef219
Pamela S. Hair, Michael D. Ward, O. John Semmes, Timothy J. Foster, Kenji M. Cunnion. (2008) Staphylococcus aureus Clumping Factor A Binds to Complement Regulator Factor I and Increases Factor I Cleavage of C3b. The Journal of Infectious Diseases 198:1, 125-133
CrossRef220
Jenny L. Martino, Wesley D. McMillian, Louis B. Polish, Anne E. Dixon. (2008) Community-acquired methicillin-resistant Staphylococcus aureus pneumonia. Respiratory Medicine 102:6, 932-934
CrossRef221
Martin E. Stryjewski, Henry F. Chambers. (2008) Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐Resistant Staphylococcus aureus. Clinical Infectious Diseases 46:S5, S368-S377
CrossRef222
Catherine Liu, Christopher J. Graber, Michael Karr, Binh An Diep, Li Basuino, Brian S. Schwartz, Mark C. Enright, Simon J. O’Hanlon, Jonathon C. Thomas, Francoise Perdreau‐Remington, Shelley Gordon, Helen Gunthorpe, Richard Jacobs, Peter Jensen, Gifford Leoung, James S. Rumack, Henry F. Chambers. (2008) A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐Resistant Staphylococcus aureus Disease in San Francisco, 2004–2005. Clinical Infectious Diseases 46:11, 1637-1646
CrossRef223
Sijing Huang, Shutian Ge, Lingwen He, Qingyun Cai, Craig A. Grimes. (2008) A remote-query sensor for predictive indication of milk spoilage. Biosensors and Bioelectronics 23:11, 1745-1748
CrossRef224
Helen W. Boucher, G. Ralph Corey. (2008) Epidemiology of Methicillin‐Resistant Staphylococcus aureus. Clinical Infectious Diseases 46:S5, S344-S349
CrossRef225
Edina Avdic, Sara E Cosgrove. (2008) Management and control strategies for community-associated methicillin-resistant Staphylococcus aureus. Expert Opinion on Pharmacotherapy 9:9, 1463-1479
CrossRef226
Rachel J. Gorwitz, Deanna Kruszon‐Moran, Sigrid K. McAllister, Geraldine McQuillan, Linda K. McDougal, Gregory E. Fosheim, Bette J. Jensen, George Killgore, Fred C. Tenover, Matthew J. Kuehnert. (2008) Changes in the Prevalence of Nasal Colonization with Staphylococcus aureus in the United States, 2001–2004. The Journal of Infectious Diseases 197:9, 1226-1234
CrossRef227
Penny A. Asbell, Daniel F. Sahm, Mary Shaw, Deborah C. Draghi, Nina P. Brown. (2008) Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. Journal of Cataract & Refractive Surgery 34:5, 814-818
CrossRef228
Jesús Rodríguez-Baño, Cornelia Bischofberger, Francisco Álvarez-Lerma, Ángel Asensio, Teresa Delgado, Dolores García-Arcal, Lola García-Ortega, M.ª Jesús Hernández, Jesús Molina-Cabrillana, Carmen Pérez-Canosa, Miquel Pujol. (2008) Vigilancia y control de Staphylococcus aureus resistente a meticilina en hospitales españoles. Documento de consenso GEIH-SEIMC y SEMPSPH. Enfermedades Infecciosas y Microbiología Clínica 26:5, 285-298
CrossRef229
Kyle J. Popovich, Bala Hota. (2008) Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Dermatologic Therapy 21:3, 167-179
CrossRef230
W. J. Munckhof, G. R. Nimmo, J. Carney, J. M. Schooneveldt, F. Huygens, J. Inman-Bamber, E. Tong, A. Morton, P. Giffard. (2008) Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. European Journal of Clinical Microbiology & Infectious Diseases 27:5, 355-364
CrossRef231
Michael Z. David, Daniel Glikman, Susan E. Crawford, Jie Peng, Kimberly J. King, Mark A. Hostetler, Susan Boyle‐Vavra, Robert S. Daum. (2008) What Is Community‐Associated Methicillin‐Resistant Staphylococcus aureus?. The Journal of Infectious Diseases 197:9, 1235-1243
CrossRef232
Thomas R. Wallin, H. Gene Hern, Bradley W. Frazee. (2008) Community-Associated Methicillin-Resistant Staphylococcus aureus. Emergency Medicine Clinics of North America 26:2, 431-455
CrossRef233
Karl J. Madaras-Kelly, Richard E. Remington, Catherine M. Oliphant, Kevin L. Sloan, David T. Bearden. (2008) Efficacy of Oral β-Lactam versus Non-β-Lactam Treatment of Uncomplicated Cellulitis. The American Journal of Medicine 121:5, 419-425
CrossRef234
A. Makinson, V. Le Moing. (2008) Nouveaux antibiotiques anti-gram+dans l’endocardite infectieuse, une place encore difficile à préciser. Annales de Cardiologie et d'Angéiologie 57:2, 88-92
CrossRef235
J. Chastre. (2008) Evolving problems with resistant pathogens. Clinical Microbiology and Infection 14:s3, 3-14
CrossRef236
Thomas R. Fritsche, Paul R. Rhomberg, Helio S. Sader, Ronald N. Jones. (2008) In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease 60:4, 399-403
CrossRef237
C. Kieffer, B. Cribier, G. Prevost, Y. Piemont, D. Lipsker. (2008) Les souches de Staphylococcus aureus méticilline-résistant communautaires en consultation externe hospitalière de dermatologie. Annales de Dermatologie et de Vénéréologie 135:4, 263-270
CrossRef238
G. S. Tillotson, D. C. Draghi, D. F. Sahm, K. M. Tomfohrde, T. del Fabro, I. A. Critchley. (2008) Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study. Journal of Antimicrobial Chemotherapy 62:1, 109-115
CrossRef239
Santiago Grau, Carlos Rubio-Terrés. (2008) Pharmacoeconomics of linezolid. Expert Opinion on Pharmacotherapy 9:6, 987-1000
CrossRef240
E. S. Kim, H. B. Kim, M.-d. Oh. (2008) Survey of community-associated methicillin-resistant Staphylococcus aureus in Korea--authors' response. Journal of Antimicrobial Chemotherapy 62:1, 212-213
CrossRef241
J.-L. Wang, S.-Y. Chen, J.-T. Wang, G. H.-M. Wu, W.-C. Chiang, P.-R. Hsueh, Y.-C. Chen, S.-C. Chang. (2008) Comparison of Both Clinical Features and Mortality Risk Associated with Bacteremia due to Community-Acquired Methicillin-Resistant Staphylococcus aureus and Methicillin-Susceptible S. aureus. Clinical Infectious Diseases 46:6, 799-806
CrossRef242
J. M. Boyce. (2008) Community-Associated Methicillin-Resistant Staphylococcus aureus as a Cause of Health Care--Associated Infection. Clinical Infectious Diseases 46:6, 795-798
CrossRef243
K. J. Popovich, R. A. Weinstein, B. Hota. (2008) Are Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Replacing Traditional Nosocomial MRSA Strains?. Clinical Infectious Diseases 46:6, 787-794
CrossRef244
Louis B. Rice, John G. Bartlett, Donald E. Craven, Dennis L. Stevens, Robert C. Moellering, George M. Eliopoulos. (2008) Emerging Treatments for Resistant Bacterial Infections and Pathogen-Focused Therapy. Infectious Diseases in Clinical Practice 16:Suppl. 1, S1-S20
CrossRef245
Derek J. Linderman, William J. Janssen. (2008) Critical Care Medicine for the Hospitalist. Medical Clinics of North America 92:2, 467-479
CrossRef246
Kwan Soo Ko, Ji-Young Lee, Jin Yang Baek, Kyong Ran Peck, Ji-Young Rhee, Ki Tae Kwon, Sang Taek Heo, Kang-Mo Ahn, Jae-Hoon Song. (2008) Characterization of Staphylococcus aureus Nasal Carriage from Children Attending an Outpatient Clinic in Seoul, Korea. Microbial Drug Resistance 14:1, 37-44
CrossRef247
Maryn McKenna. (2008) The Many Faces of MRSA: Community-Acquired Infection Knows No Bounds. Annals of Emergency Medicine 51:3, 285-288
CrossRef248
Abel N. Kho, Paul R. Dexter, Jeff S. Warvel, Anne W. Belsito, Marie Commiskey, Stephen J. Wilson, Siu L. Hui, Clement J. McDonald. (2008) An effective computerized reminder for contact isolation of patients colonized or infected with resistant organisms. International Journal of Medical Informatics 77:3, 194-198
CrossRef249
Ruth Miller, Hanif Esmail, Tim Peto, Sarah Walker, Derrick Crook, David Wyllie. (2008) Is MRSA admission bacteraemia community-acquired? A case control study. Journal of Infection 56:3, 163-170
CrossRef250
Kim M. Levenhagen. (2008) Community-acquired methicillin-resistantStaphylococcus aureus: an emerging concern for physical therapists: Discussion. Physiotherapy Research International 13:1, 9-17
CrossRef251
Michelle E. Koski, Romano T. DeMarco, John W. Brock, John C. Pope, Mark C. Adams, John C. Thomas. (2008) Community Associated Methicillin Resistant Staphylococcal Infections in a Pediatric Urology Practice. The Journal of Urology 179:3, 1098-1101
CrossRef252
Fredrick M. Abrahamian, David A. Talan, Gregory J. Moran. (2008) Management of Skin and Soft-Tissue Infections in the Emergency Department. Infectious Disease Clinics of North America 22:1, 89-116
CrossRef253
Vincent A. Deramo, James C. Lai, Jules Winokur, Jodi Luchs, Ira J. Udell. (2008) Visual Outcome and Bacterial Sensitivity After Methicillin-Resistant Staphylococcus aureus–Associated Acute Endophthalmitis. American Journal of Ophthalmology 145:3, 413-417.e1
CrossRef254
R. N. Jones. (2008) Key considerations in the treatment of complicated staphylococcal infections. Clinical Microbiology and Infection 14, 3-9
CrossRef255
Nelson Nicolasora, Daniel R. Kaul. (2008) Infectious Disease Emergencies. Medical Clinics of North America 92:2, 427-441
CrossRef256
F. R. DeLeo, M. Otto. (2008) An antidote for Staphylococcus aureus pneumonia?. Journal of Experimental Medicine 205:2, 271-274
CrossRef257
Jason E. Farley. (2008) Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. Journal of the American Academy of Nurse Practitioners 20:2, 85-92
CrossRef258
Brendan J. Kilbane, Sally L. Reynolds. (2008) Emergency Department Management of Community-Acquired Methicillin-Resistant Staphylococcus aureus. Pediatric Emergency Care 24:2, 109-114
CrossRef259
J RUSH PIERCE, QAISER SAEED, WILLIAM R. DAVIS. (2008) Prostatic Abscess Due to Community-Acquired Methicillin-Resistant Staphylococcus aureus. The American Journal of the Medical Sciences 335:2, 154-156
CrossRef260
Michael W Ellis. (2008) Is antimicrobial therapy needed to manage uncomplicated skin and soft-tissue abscesses?. Expert Review of Anti-infective Therapy 6:1, 9-13
CrossRef261
Joseph L. Kuti, Michael Dowzicky, David P. Nicolau. (2008) Pharmacodynamic Performance of Tigecycline versus Common Intravenous Antibiotics for the Empiric Treatment of Complicated Skin and Skin Structure Infections. Surgical Infections 9:1, 57-66
CrossRef262
Elsie T. Nguyen, Jeffrey P. Kanne, Linda M. N. Hoang, Steven Reynolds, Vinay Dhingra, Elizabeth Bryce, Nestor L. Müller. (2008) Community-acquired Methicillin-resistant Staphylococcus aureus Pneumonia. Journal of Thoracic Imaging 23:1, 13-19
CrossRef263
James S Lewis, Michael W Ellis. (2008) Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management. Current Opinion in Internal Medicine 7:1, 65-70
CrossRef264
(2008) Super bugs: super problems. International Journal of Dental Hygiene 6:1, 72-73
CrossRef265
Rachel J. Gorwitz. (2008) Understanding the Success of Methicillin‐Resistant Staphylococcus aureus Strains Causing Epidemic Disease in the Community. The Journal of Infectious Diseases 197:2, 179-182
CrossRef266
B. Spellberg, R. Guidos, D. Gilbert, J. Bradley, H. W. Boucher, W. M. Scheld, J. G. Bartlett, J. Edwards, . (2008) The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America. Clinical Infectious Diseases 46:2, 155-164
CrossRef267
Jason G Newland, Gregory L Kearns. (2008) Treatment Strategies for Methicillin-Resistant Staphylococcus aureus Infections in Pediatrics. Pediatric Drugs 10:6, 367-378
CrossRef268
Fernando Chaves Sánchez, Maria Daskalaki, Joaquín R. Otero. (2008) Epidemiología de las infecciones por grampositivos multirresistentes. Enfermedades Infecciosas y Microbiología Clínica 26, 4-12
CrossRef269
P. Bernard, V. Jarlier, A. Santerre-Henriksen. (2008) Sensibilité aux antibiotiques des souches de Staphylococcus aureus responsables d’infections cutanées communautaires. Annales de Dermatologie et de Vénéréologie 135:1, 13-19
CrossRef270
Rachel J. Gorwitz. (2008) A Review of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections. The Pediatric Infectious Disease Journal 27:1, 1-7
CrossRef271
Chulmin Park, Dong-Gun Lee, Su-Mi Choi, Sun Hee Park, Jung-Hyun Choi, Jin-Hong Yoo, Ji An Hur, Wan-Shik Shin. (2008) A Case of Perianal Abscess due to Panton-Valentine Leukocidin Positive Community-Associated Methicillin-Resistant Staphylococcus aureus : Report in Korea and Literature Review from the Far East. Infection and Chemotherapy 40:2, 121
CrossRef272
(2008) CrossRef Listing of Deleted DOIs. CrossRef Listing of Deleted DOIs
CrossRef273
Hung-Chin Tsai, Pei-Jiuan Chao, Cheng-Len Sy, Susan Shin-Jung Lee, Yao-Shen Chen, Shue-Ren Wann, Yung-Ching Liu. (2008) Community-Associated Methicillin-Resistant Staphylococcus aureus Infective Endocarditis with Panton-Valentine Leukocidin Gene in an Injection Drug User with HIV Infection. Internal Medicine 47:16, 1485-1489
CrossRef274
Giovanni B. Orsi. (2008) MRSA: an old and new enemy. Healthcare Infection 13:3, 73
CrossRef275
Armando Paez, Daniel Skiest. (2008) Methicillin-resistant Staphylococcus aureus: From the hospital to the community. Current Infectious Disease Reports 10:1, 14-21
CrossRef276
Antoine Rabbat, Gérard J. Huchon. 2008. Bacterial Pneumonia. , 333-350.
CrossRef277
Félix Gutiérrez, Mar Masiá. (2008) Improving Outcomes of Elderly Patients with Community-Acquired Pneumonia. Drugs & Aging 25:7, 585-610
CrossRef278
S. M. Hamilton, A. E. Bryant, K. C. Carroll, V. Lockary, Y. Ma, E. McIndoo, L. G. Miller, F. Perdreau-Remington, J. Pullman, G. F. Risi, D. B. Salmi, D. L. Stevens. (2007) In Vitro Production of Panton-Valentine Leukocidin among Strains of Methicillin-Resistant Staphylococcus aureus Causing Diverse Infections. Clinical Infectious Diseases 45:12, 1550-1558
CrossRef279
Joseph Rahimian, Raymond Khan, Keith A. LaScalea. (2007) Does Nasal Colonization or Mupirocin Treatment Affect Recurrence of Methicillin‐Resistant Staphylococcus aureus Skin and Skin Structure Infections? • . Infection Control and Hospital Epidemiology 28:12, 1415-1416
CrossRef280
J. Solera, G. Jarava. (2007) Avances en la antibioterapia empírica. Aplicaciones prácticas al tratamiento de las neumonías, de las infecciones urinarias, abdominales, de partes blandas y de sepsis de origen desconocido. Medicine - Programa de Formación Médica Continuada Acreditado 9:92, 5959-5966
CrossRef281
Jane D. Siegel, Emily Rhinehart, Marguerite Jackson, Linda Chiarello. (2007) Management of multidrug-resistant organisms in health care settings, 2006. American Journal of Infection Control 35:10, S165-S193
CrossRef282
Rong Wang, Kevin R Braughton, Dorothee Kretschmer, Thanh-Huy L Bach, Shu Y Queck, Min Li, Adam D Kennedy, David W Dorward, Seymour J Klebanoff, Andreas Peschel, Frank R DeLeo, Michael Otto. (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nature Medicine 13:12, 1510-1514
CrossRef283
Sally F. Bloomfield, Allison E. Aiello, Barry Cookson, Carol O'Boyle, Elaine L. Larson. (2007) The effectiveness of hand hygiene procedures in reducing the risks of infections in home and community settings including handwashing and alcohol-based hand sanitizers. American Journal of Infection Control 35:10, S27-S64
CrossRef284
Heather C. Yun, Michael W. Ellis, James H. Jorgensen. (2007) Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees. Diagnostic Microbiology and Infectious Disease 59:4, 463-466
CrossRef285
Timothy C. Lee, Matthew M. Carrick, Bradford G. Scott, Joseph C. Hodges, Hoang Q. Pham. (2007) Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. The American Journal of Surgery 194:6, 809-813
CrossRef286
August J. Valenti. 2007. The Impact of Hospital Epidemiology on the Management and Control of Antimicrobial Resistance: Issues and Controversies. , 397-432.
CrossRef287
Cindy A Loffler, Conan MacDougall. (2007) Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections. Expert Review of Anti-infective Therapy 5:6, 961-981
CrossRef288
K. Krziwanek, C. Luger, B. Sammer, S. Stumvoll, M. Stammler, S. Metz-Gercek, H. Mittermayer. (2007) PVL-positive MRSA in Austria. European Journal of Clinical Microbiology & Infectious Diseases 26:12, 931-935
CrossRef289
Eric R. Howell, Charles M. Phillips. (2007) Cutaneous Manifestations of Staphylococcus aureus Disease. SKINmed 6:6, 274-279
CrossRef290
Gerard J. Bruno, Joanna M. Bruno, Alan A. Miyake. (2007) Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection With Fatal Necrotizing Pneumonia From Lip Abscess: A Case Report. Journal of Oral and Maxillofacial Surgery 65:11, 2350-2353
CrossRef291
Oluwadamilola A. Adeyemi, Thomas H. Grant, Gary A. Noskin. (2007) Productive Cough With Tinge of Blood and Fever. Infectious Diseases in Clinical Practice 15:6, 385-388
CrossRef292
(2007) Update on Emerging Infections: News from the Centers for Disease Control and Prevention. Annals of Emergency Medicine 50:5, 612-614
CrossRef293
Irma Casas, Nieves Sopena, Maria Esteve, Maria Dolores Quesada, Isabel Andres, Lourdes Matas, Silvia Blanco, Maria Luisa Pedro‐Botet, Montse Caraballo, Vicente Ausina, Miquel Sabria. (2007) Prevalence of and Risk Factors for Methicillin‐Resistant Staphylococcus aureus Carriage at Hospital Admission • . Infection Control and Hospital Epidemiology 28:11, 1314-1317
CrossRef294
Bradley W. Frazee. (2007) Commentary. Annals of Emergency Medicine 50:5, 614-616
CrossRef295
Robert C. Moellering, John R. Graybill, John E. McGowan, Lawrence Corey. (2007) Antimicrobial resistance prevention initiative—an update: Proceedings of an expert panel on resistance. American Journal of Infection Control 35:9, S1-S23
CrossRef296
J. Dissemond. (2007) Praktische Konsequenzen durch den Nachweis von MRSA in chronischen Wunden. Der Hautarzt 58:11, 952-958
CrossRef297
Kevin O Kisich, Michael D Howell, Mark Boguniewicz, Heather R Heizer, Nori U Watson, Donald Y M Leung. (2007) The Constitutive Capacity of Human Keratinocytes to Kill Staphylococcus aureus Is Dependent on β-Defensin 3. Journal of Investigative Dermatology 127:10, 2368-2380
CrossRef298
F.M.E. Wagenlehner, K.G. Naber, E. Bambl, U. Raab, C. Wagenlehner, D. Kahlau, C. Höller, W. Witte, W. Weidner, N. Lehn, S. Harbarth, H.-J. Linde. (2007) Management of a large healthcare-associated outbreak of Panton–Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus in Germany. Journal of Hospital Infection 67:2, 114-120
CrossRef299
Werner E. Bischoff, Brian K. Tucker, Michelle L. Wallis, Beth A. Reboussin, Michael A. Pfaller, Frederick G. Hayden, Robert J. Sherertz. (2007) Preventing the Airborne Spread of Staphylococcus aureus by Persons With the Common Cold: Effect of Surgical Scrubs, Gowns, and Masks • . Infection Control and Hospital Epidemiology 28:10, 1148-1154
CrossRef300
A. F. Shorr. (2007) Epidemiology of Staphylococcal Resistance. Clinical Infectious Diseases 45:Supplement 3, S171-S176
CrossRef301
E. M. Stam-Bolink, D. Mithoe, W. H. Baas, J. P. Arends, A. V. M. Möller. (2007) Spread of a methicillin-resistant Staphylococcus aureus ST80 strain in the community of the northern Netherlands. European Journal of Clinical Microbiology & Infectious Diseases 26:10, 723-727
CrossRef302
Christina Kurkowski. (2007) CA-MRSA. Orthopaedic Nursing 26:5, 310-314
CrossRef303
Jake E. Krige, Kimberly Lindfield, Lawrence Friedrich, Constance Otradovec, William J. Martone, David E. Katz, Frank Tally. (2007) Effectiveness and duration of daptomycin therapy in resolving clinical symptoms in the treatment of complicated skin and skin structure infections*. Current Medical Research and Opinion 23:9, 2147-2156
CrossRef304
Kyle J. Popovich, Bala Hota, Robert A. Weinstein. (2007) Treatment of community-associated methicillin-resistant Staphylococcus aureus. Current Infectious Disease Reports 9:5, 398-407
CrossRef305
Hye-Yoon Jeong, Jung-Eun Lee, Bo-Kyung Choi, Kyung-Won Seo, Seung-Hee Park, Young-Lim Kim, Kyoung-Min Baek, Kyungwon Lee, Dong-Kwon Rhee. (2007) Molecular Epidemiology of Community-Associated Antimicrobial-Resistant Staphylococcus aureus in Seoul, Korea (2003): Pervasiveness of Multidrug-Resistant SCC mec Type II Methicillin-Resistant S. aureus. Microbial Drug Resistance 13:3, 178-185
CrossRef306
Emily Kajita, Justin T. Okano, Erin N. Bodine, Scott P. Layne, Sally Blower. (2007) Modelling an outbreak of an emerging pathogen. Nature Reviews Microbiology 5:9, 700-709
CrossRef307
Fredrick M. Abrahamian, Eric W. Snyder. (2007) Community-associated methicillin-resistant Staphylococcus aureus: Incidence, clinical presentation, and treatment decisions. Current Infectious Disease Reports 9:5, 391-397
CrossRef308
H. W. Boucher, G. Sakoulas. (2007) Perspectives on Daptomycin Resistance, with Emphasis on Resistance in Staphylococcus aureus. Clinical Infectious Diseases 45:5, 601-608
CrossRef309
Christopher W.A. Baugh, Stephen H. Thomas, Eric S. Nadel, David F.M. Brown. (2007) Complicated Soft Tissue Infection. The Journal of Emergency Medicine 33:2, 181-185
CrossRef310
Salvador Bello Dronda, Manuel Vilá Justribó. (2007) ¿Seguiremos teniendo antibióticos mañana?. Archivos de Bronconeumología 43:8, 450-459
CrossRef311
Gerald R. Donowitz, Heather L. Cox. (2007) Bacterial Community-Acquired Pneumonia in Older Patients. Clinics in Geriatric Medicine 23:3, 515-534
CrossRef312
E. Yoko Furuya, Heather A. Cook, Mei-Ho Lee, Maureen Miller, Elaine Larson, Sandra Hyman, Phyllis Della-Latta, Eneida A. Mendonca, Franklin D. Lowy. (2007) Community-associated methicillin-resistant Staphylococcus aureus prevalence: How common is it? A methodological comparison of prevalence ascertainment. American Journal of Infection Control 35:6, 359-366
CrossRef313
H. H. Balkhy, Z. A. Memish, M. A. Almuneef, G. C. Cunningham, C. Francis, K. C. Fong, Z. B. Nazeer, E. Tannous. (2007) Methicillin‐Resistant Staphylococcus aureus: A 5‐Year Review of Surveillance Data in a Tertiary Care Hospital in Saudi Arabia • . Infection Control and Hospital Epidemiology 28:8, 976-982
CrossRef314
Daum, Robert S., . (2007) Skin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus. New England Journal of Medicine 357:4, 380-390
Full Text315
Thomas P Lodise, Peggy S McKinnon. (2007) Burden of Methicillin-Resistant Staphylococcus aureus : Focus on Clinical and Economic Outcomes. Pharmacotherapy 27:7, 1001-1012
CrossRef316
Jeffrey B. Albright, Mark J. Pidala, Joseph R. Cali, Michael J. Snyder, Theodoros Voloyiannis, Randolph H. Bailey. (2007) MRSA-Related Perianal Abscesses: An Underrecognized Disease Entity. Diseases of the Colon & Rectum 50:7, 996-1003
CrossRef317
Robert P. Baughman, Donna Winget, David P. Nicolau. (2007) Bronchoscopic Evaluation of Moxifloxacin Therapy in Acute Exacerbations of Chronic Bronchitis Previously Treated With Azithromycin. Journal of Bronchology 14:3, 144-148
CrossRef318
N.Z. Haque, S.L. Davis, C.L. Manierski, D. Vager, S.M. Donabedian, M.B. Perri, R. Sabbagh, F. Cheema, M.J. Zervos. (2007) Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA). International Journal of Antimicrobial Agents 30:1, 72-77
CrossRef319
Robert C. Moellering, John R. Graybill, John E. McGowan, Lawrence Corey. (2007) Antimicrobial Resistance Prevention Initiative—An Update: Proceedings of an Expert Panel on Resistance. The American Journal of Medicine 120:7, S4-S25
CrossRef320
Scott Robert Witherspoon, Preston H. Blomquist. (2007) Methicillin-Resistant Staphylococcus
Presented in part at: Association for Research in Vision and Ophthalmology Annual Meeting, May 3, 2006, Fort Lauderdale, Florida. Supported in part by an unrestricted research grant from Research to Prevent Blindness, Inc., New York, New York.. Ophthalmology 114:7, 1420-1421
CrossRef321
Clement L. Ren, Wayne J. Morgan, Michael W. Konstan, Michael S. Schechter, Jeffrey S. Wagener, Kathryn A. Fisher, Warren E. Regelmann, . (2007) Presence of methicillin resistantStaphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatric Pulmonology 42:6, 513-518
CrossRef322
Thomas R. Talbot, Joseph J. Nania, Patty W. Wright, Ian Jones, Dominik Aronsky. (2007) Evaluation of the Microbiology of Soft‐Tissue Abscesses in the Era of Community‐Associated Strains of Methicillin‐Resistant Staphylococcus aureus: An Argument for Empirical Contact Precautions • . Infection Control and Hospital Epidemiology 28:6, 730-732
CrossRef323
Daniel Christopher Allison, Timothy Miller, Paul Holtom, Michael J Patzakis, Charalampos G Zalavras. (2007) Microbiology of Upper Extremity Soft Tissue Abscesses in Injecting Drug Abusers. Clinical Orthopaedics and Related Research PAP,
CrossRef324
Aaron A. R. Tobian, Scott K. Ober. (2007) Dual Perinephric and Prostatic Abscesses from Methacillin-resistant Staphylococcus aureus. Southern Medical Journal 100:5, 515-516
CrossRef325
B E Shaw, T Boswell, J L Byrne, C Yates, N H Russell. (2007) Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak. Bone Marrow Transplantation 39:10, 623-629
CrossRef326
Christopher Burlak, Carl H. Hammer, Mary-Ann Robinson, Adeline R. Whitney, Martin J. McGavin, Barry N. Kreiswirth, Frank R. DeLeo. (2007) Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection. Cellular Microbiology 9:5, 1172-1190
CrossRef327
Arunabh Talwar, Hans Lee, Alan Fein. (2007) Community-acquired pneumonia: what is relevant and what is not?. Current Opinion in Pulmonary Medicine 13:3, 177-185
CrossRef328
Daniel J. Skiest, Katia Brown, Travis W. Cooper, Holly Hoffman-Roberts, Huda R. Mussa, Alan C. Elliott. (2007) Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. Journal of Infection 54:5, 427-434
CrossRef329
Brian T. Tsuji, Michael J. Rybak, Chrissy M. Cheung, Muhammad Amjad, Glenn W. Kaatz. (2007) Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. Diagnostic Microbiology and Infectious Disease 58:1, 41-47
CrossRef330
C Buddy Creech, B Gayle Johnson, Randall E. Bartilson, Edmund Yang, Frederick E. Barr. (2007) Increasing use of extracorporeal life support in methicillin-resistant Staphylococcus aureus sepsis in children*. Pediatric Critical Care Medicine 8:3, 231-235
CrossRef331
Dirk M. Elston. (2007) Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus: Management Principles and Selection of Antibiotic Therapy. Dermatologic Clinics 25:2, 157-164
CrossRef332
Priya M. Rajendran, David M. Young, Toby Maurer, Henry F. Chambers, Mark A. Jacobson, Hobart W. Harris. (2007) Antibiotic Use in The Treatment of Soft Tissue Abscesses: A Survey of Current Practice. Surgical Infections 8:2, 237-238
CrossRef333
Marion Gabillot-Carré, Jean-Claude Roujeau. (2007) Acute bacterial skin infections and cellulitis. Current Opinion in Infectious Diseases 20:2, 118-123
CrossRef334
Lilibeth Pineda, Ali A El Solh. (2007) Severe community-acquired pneumonia: approach to therapy. Expert Opinion on Pharmacotherapy 8:5, 593-606
CrossRef335
Concepcion F. Estivariz, Sarah Y. Park, Jeffrey C. Hageman, Jeffrey Dvorin, Marian M. Melish, Rose Arpon, Pat Coon, Susan Slavish, Mary Kim, Linda K. McDougal, Bette Jensen, Sigrid McAllister, David Lonsway, George Killgore, Paul E. Effler, Daniel B. Jernigan. (2007) Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001–2003. Journal of Infection 54:4, 349-357
CrossRef336
J. J. Ruhe, N. Smith, R. W. Bradsher, A. Menon. (2007) Community-Onset Methicillin-Resistant Staphylococcus aureus Skin and Soft-Tissue Infections: Impact of Antimicrobial Therapy on Outcome. Clinical Infectious Diseases 44:6, 777-784
CrossRef337
R. J. Gorwitz. (2007) The Role of Ancillary Antimicrobial Therapy for Treatment of Uncomplicated Skin Infections in the Era of Community-Associated Methicillin-Resistant Staphylococcus aureus. Clinical Infectious Diseases 44:6, 785-787
CrossRef338
Kabir Sardana, Vikas Manchanda, Monika Rajpal, Vijay K. Garg, Dinesh S. Chauhan. (2007) Bacterial pyoderma in children and therapeutic options including management of community-acquired methicillin resistant Staphylococcus aureus. International Journal of Dermatology 46:3, 309-313
CrossRef339
L. A. Mandell, R. G. Wunderink, A. Anzueto, J. G. Bartlett, G. D. Campbell, N. C. Dean, S. F. Dowell, T. M. File, D. M. Musher, M. S. Niederman, A. Torres, C. G. Whitney. (2007) Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 44:Supplement 2, S27-S72
CrossRef340
T. Mückley, M. Diefenbeck, G. O. Hofmann. (2007) MRSA-Infektionen am muskulo-skelettalen System. Trauma und Berufskrankheit 9:S01, S69-S74
CrossRef341
Marisel Segarra-Newnham. (2007) Development of a Treatment Algorithm for <i>Staphylococcal</i> Pyoderma in the Emergency Department. Hospital Pharmacy 42:3, 226-229
CrossRef342
L. G. Miller, C. Quan, A. Shay, K. Mostafaie, K. Bharadwa, N. Tan, K. Matayoshi, J. Cronin, J. Tan, G. Tagudar, A. S. Bayer. (2007) A Prospective Investigation of Outcomes after Hospital Discharge for Endemic, Community-Acquired Methicillin-Resistant and -Susceptible Staphylococcus aureus Skin Infection. Clinical Infectious Diseases 44:4, 483-492
CrossRef343
L. G. Miller, F. P. Remington, A. S. Bayer, B. Diep, N. Tan, K. Bharadwa, J. Tsui, J. Perlroth, A. Shay, G. Tagudar, U. Ibebuogu, B. Spellberg. (2007) Clinical and Epidemiologic Characteristics Cannot Distinguish Community-Associated Methicillin-Resistant Staphylococcus aureus Infection from Methicillin-Susceptible S. aureus Infection: A Prospective Investigation. Clinical Infectious Diseases 44:4, 471-482
CrossRef344
Ö. Friberg, R. Svedjeholm, J. Källman, B. Söderquist. (2007) Incidence, microbiological findings, and clinical presentation of sternal wound infections after cardiac surgery with and without local gentamicin prophylaxis. European Journal of Clinical Microbiology & Infectious Diseases 26:2, 91-97
CrossRef345
U. Reischl, M. J. Tuohy, G. S. Hall, G. W. Procop, N. Lehn, H. Linde. (2007) Rapid detection of Panton–Valentine leukocidin-positive Staphylococcus aureus by real-time PCR targeting the lukS-PV gene. European Journal of Clinical Microbiology & Infectious Diseases 26:2, 131-135
CrossRef346
Richard H Drew. (2007) Emerging Options for Treatment of Invasive, Multidrug-Resistant Staphylococcus aureus Infections. Pharmacotherapy 27:2, 227-249
CrossRef347
Helio S Sader, Ronald N Jones. (2007) Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections. Expert Review of Anti-infective Therapy 5:1, 29-43
CrossRef348
Stanley A. Nasraway. (2007) ???Search and destroy??? for methicillin-resistant Staphylococcus aureus in the intensive care unit: Should this now be the standard of care?*. Critical Care Medicine 35:2, 642-644
CrossRef349
Bradley N. Younggren, Mark Denny. (2007) Emergency Management of Difficult Wounds: Part II. Emergency Medicine Clinics of North America 25:1, 123-134
CrossRef350
Philip R. Cohen. (2007) Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention. International Journal of Dermatology 46:1, 1-11
CrossRef351
Garrett E. Schramm, Jennifer A. Johnson, Joshua A. Doherty, Scott T. Micek, Marin H. Kollef. (2007) Increasing Incidence of Sterile‐Site Infections Due to Non–Multidrug‐Resistant, Oxacillin‐Resistant Staphylococcus aureus Among Hospitalized Patients • . Infection Control and Hospital Epidemiology 28:1, 95-97
CrossRef352
Su Young Lee, Hong Wei Fan, Christina Sutherland, Andrew C DeRyke, David P Nicolau. (2007) Antibacterial Effects of Moxifloxacin and Levofloxacin Simulating Epithelial Lining Fluid Concentrations against Community-Acquired Methicillin-Resistant Staphylococcus aureus. Drugs in R & D 8:2, 69-77
CrossRef353
Andrew F Shorr. (2007) Epidemiology and Economic Impact??of Meticillin-Resistant Staphylococcus aureus. PharmacoEconomics 25:9, 751-768
CrossRef354
José Barberán, Alex Soriano, Álvaro Pascual, Javier Cobo, Javier Ariza, Xavier Flores, Antonio Guerrero, José Hernández-Quero, Cristina Fernández, José Cordero, José Ramón Azanza. (2007) Update on osteo-articular infections and severe skin and soft tissue infections. Enfermedades Infecciosas y Microbiología Clínica 25, 28-36
CrossRef355
Dirk M. Elston. (2007) Community-acquired methicillin-resistant Staphylococcus aureus. Journal of the American Academy of Dermatology 56:1, 1-16
CrossRef356
James Robert Roberts. (2007) Lap Dancer’s Lament: An Occupational Hazard Related to Community-Associated Methicillin-Resistant Staphylococcus aureus. Annals of Emergency Medicine 49:1, 116-117
CrossRef357
David J. Karras, Wayne A. Satz, Jeffrey Barrett. 2007. Management of Infectious Diseases. , 63-71.
CrossRef358
Sang Taek Heo, Kyong Ran Peck, Seong Yeol Ryu, Ki Tae Kwon, Kwan Soo Ko, Won Sup Oh, Nam Yong Lee, Jae-Hoon Song. (2007) Analysis of Methicillin Resistance among Staphylococcus aureus Blood Isolates in an Emergency Department. Journal of Korean Medical Science 22:4, 682
CrossRef359
Kerry L LaPlante, Michael J Rybak, Muhammad Amjad, Glenn W Kaatz. (2007) Antimicrobial Susceptibility and Staphylococcal Chromosomal Cassette mec Type in Community- and Hospital-Associated Methicillin-Resistant Staphylococcus aureus. Pharmacotherapy 27:1, 3-10
CrossRef360
A. W. Karchmer. (2006) From theory to practice: resistance in Staphylococcus aureus and new treatments. Clinical Microbiology and Infection 12:s8, 15-21
CrossRef361
K. Sardana, V. Manchanda, V.K. Garg. (2006) Community-acquired methicillin-resistant Staphylococcus aureus: different populations, different results. British Journal of Dermatology 155:6, 1298-1299
CrossRef362
Susan I Gerber. (2006) Describing the methicillin-resistant Staphylococcus aureus epidemic: a public health challenge. Expert Review of Anti-infective Therapy 4:6, 905-907
CrossRef363
Susan Salter Davidson, William H. Benjamin. (2006) Risk of infection and tracking of work-related infectious diseases in the funeral industry. American Journal of Infection Control 34:10, 655-660
CrossRef364
Manuel Cortazal, Barbara M. Soule, William R. Jarvis. (2006) Editorial. American Journal of Infection Control 34:10, 613-615
CrossRef365
William J Ledger. (2006) Prophylactic antibiotics in obstetrics–gynecology: a current asset, a future liability?. Expert Review of Anti-infective Therapy 4:6, 957-964
CrossRef366
Fred A. Lopez, Serge Lartchenko. (2006) Skin and Soft Tissue Infections. Infectious Disease Clinics of North America 20:4, 759-772
CrossRef367
Douglas N Fish. (2006) Meropenem in the treatment of complicated skin and soft tissue infections. Therapeutics and Clinical Risk Management 2:4, 401-415
CrossRef368
Philip A. Giordano, Dirk Elston, Bolanle K. Akinlade, Kurt Weber, Gerard F. Notario, Todd A. Busman, Mary Cifaldi, Angela M. Nilius. (2006) Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults*. Current Medical Research and Opinion 22:12, 2419-2428
CrossRef369
Michael S. Gelfand, Kerry O. Cleveland, Robert K. Heck, Rekha Goswami. (2006) Pathological Fracture in Acute Osteomyelitis of Long Bones Secondary to Community-Acquired Methicillin-Resistant Staphylococcus aureus: Two Cases and Review of the Literature. The American Journal of the Medical Sciences 332:6, 357-360
CrossRef370
Jennifer Le, Jay M Lieberman. (2006) Management of Community-Associated Methicillin-Resistant Staphylococcus aureus Infections in Children. Pharmacotherapy 26:12, 1758-1770
CrossRef371
Takayoshi Kato, Hisato Takagi, Yukihiro Matsuno, Matsuhisa Imaizumi, Takuya Umemoto. (2006) High-pressure irrigation and gentian-violet application for mediastinitis following replacement of ascending aorta and aortic valve. Heart and Vessels 21:6, 392-394
CrossRef372
Sandra R. Arnold, David Elias, Steven C. Buckingham, Eddie D. Thomas, Eduardo Novais, Alexandre Arkader, Cassandra Howard. (2006) Changing Patterns of Acute Hematogenous Osteomyelitis and Septic Arthritis. Journal of Pediatric Orthopaedics 26:6, 703-708
CrossRef373
G. Peralta, E. Padrón, M. P. Roiz, I. Benito, J. C. Garrido, F. Talledo, M. J. Rodríguez-Lera, L. Ansorena, M. B. Sánchez. (2006) Risk factors for bacteremia in patients with limb cellulitis. European Journal of Clinical Microbiology & Infectious Diseases 25:10, 619-626
CrossRef374
Pamela Mehta, Stephen B Schnall, Charalampos G Zalavras. (2006) Septic Arthritis of the Shoulder, Elbow, and Wrist. Clinical Orthopaedics and Related Research 451, 42-45
CrossRef375
James Hedrick. (2006) Cephalosporins for uncomplicated skin and skin structure infections in emerging community-acquired MRSA. Expert Opinion on Pharmacotherapy 7:15, 2019-2024
CrossRef376
David J. Weber, William A. Rutala. (2006) Use of Germicides in the Home and the Healthcare Setting: Is There a Relationship Between Germicide Use and Antibiotic Resistance? • . Infection Control and Hospital Epidemiology 27:10, 1107-1119
CrossRef377
Aaron E. Chen, Mitchell Goldstein, Karen Carroll, Xiaoyan Song, Trish M. Perl, George K. Siberry. (2006) Evolving Epidemiology of Pediatric Staphylococcus aureus Cutaneous Infections in a Baltimore Hospital. Pediatric Emergency Care 22:10, 717-723
CrossRef378
Jaffar A. Al‐Tawfiq. (2006) Incidence and Epidemiology of Methicillin‐Resistant Staphylococcus aureus Infection in a Saudi Arabian Hospital, 1999‐2003 • . Infection Control and Hospital Epidemiology 27:10, 1137-1139
CrossRef379
Susan L. Davis, Michael J. Rybak, Muhammad Amjad, Glenn W. Kaatz, Peggy S. McKinnon. (2006) Characteristics of Patients With Healthcare‐Associated Infection Due to SCC mec Type IV Methicillin‐Resistant Staphylococcus aureus • . Infection Control and Hospital Epidemiology 27:10, 1025-1031
CrossRef380
Donald C. Vinh, John M. Embil. (2006) Severe skin and soft tissue infections and associated critical illness. Current Infectious Disease Reports 8:5, 375-383
CrossRef381
Su Young Lee, Joseph L. Kuti, David P. Nicolau. (2006) Empiric Pharmacodynamic Performance of 9 Antimicrobials Against Pathogens Implicated in the Cause of Complicated Skin and Soft Tissue Infections. Infectious Diseases in Clinical Practice 14:5, 289-295
CrossRef382
Warren S. Joseph. (2006) Optimal management of uncomplicated skin and skin structure infections of the lower extremity. Current Infectious Disease Reports 8:5, 384-389
CrossRef383
Susan J. Rehm. (2006) Treatment of Serious Infections Caused by Methicillin-resistant Staphylococcus aureus. Infectious Diseases in Clinical Practice 14:5, 251-253
CrossRef384
Moran, Gregory J., Krishnadasan, Anusha, Gorwitz, Rachel J., Fosheim, Gregory E., McDougal, Linda K., Carey, Roberta B., Talan, David A., . (2006) Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department. New England Journal of Medicine 355:7, 666-674
Full Text385
John Seal, Loretto Glynn, Mindy Statter, Donald Liu. (2006) A high prevalence of methicillin-resistant Staphylococcus aureus among surgically drained soft-tissue infections in pediatric patients. Pediatric Surgery International 22:8, 683-687
CrossRef386
D. Jeyaratnam, J.D. Edgeworth, G.L. French. (2006) Enhanced surveillance of meticillin-resistant Staphylococcus aureus bacteraemia in a London teaching hospital. Journal of Hospital Infection 63:4, 365-373
CrossRef387
Tina Rutar, Henry F. Chambers, J. Brooks Crawford, Francoise Perdreau-Remington, Orin M. Zwick, Michael Karr, Jennifer J. Diehn, Kimberly P. Cockerham. (2006) Ophthalmic Manifestations of Infections Caused by the USA300 Clone of Community-Associated Methicillin-Resistant Staphylococcus aureus. Ophthalmology 113:8, 1455-1462
CrossRef388
Jill C. Roberts, Andrew C. Cannons, Philip T. Amuso, Jacqueline Cattani. (2006) Virtual digest identification of secondary enzymes for use in pulsed-field gel electrophoresis of Staphylococcus aureus. Journal of Microbiological Methods 66:2, 362-368
CrossRef389
Garrett E. Schramm, Jennifer A. Johnson, Joshua A. Doherty, Scott T. Micek, Marin H. Kollef. (2006) Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment*. Critical Care Medicine 34:8, 2069-2074
CrossRef390
Ravi V. Kiran, Beth McCampbell, Adam P. Angeles, Richard D. Montilla, Carlos Medina, Avir Mitra, John Gaughn, Julia Spears, Amit Mitra. (2006) Increased Prevalence of Community-Acquired Methicillin-Resistant Staphylococcus aureus in Hand Infections at an Urban Medical Center. Plastic and Reconstructive Surgery 118:1, 161-166
CrossRef391
Su Young Lee, Hong Wei Fan, Joseph L Kuti, David P Nicolau. (2006) Update on daptomycin: the first approved lipopeptide antibiotic. Expert Opinion on Pharmacotherapy 7:10, 1381-1397
CrossRef392
Ian A. Critchley. (2006) Eradication of MRSA nasal colonization as a strategy for infection prevention. Drug Discovery Today: Therapeutic Strategies 3:2, 189-195
CrossRef393
Scott W. Fleming, Lauren Hinson Brown, Sarah E. Tice. (2006) Community-acquired methicillin-resistant Staphylococcus aureus skin infections: Report of a local outbreak and implications for emergency department care. Journal of the American Academy of Nurse Practitioners 18:6, 297-300
CrossRef394
Allison E Aiello, Franklin D Lowy, Lester N Wright, Elaine L Larson. (2006) Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. The Lancet Infectious Diseases 6:6, 335-341
CrossRef395
Irene Tien. (2006) Update on the management of skin, soft-tissue, and osteoarticular infections in children. Current Opinion in Pediatrics 18:3, 254-259
CrossRef396
Ali A El Solh. (2006) Moxifloxacin in the treatment of elderly patients with community-acquired pneumonia. Aging Health 2:3, 383-393
CrossRef397
M HALEM, J TRENT, J GREEN, F KERDEL. (2006) Community-Acquired Methicillin Resistant Staphylococcus aureus Skin Infection. Seminars in Cutaneous Medicine and Surgery 25:2, 68-71
CrossRef398
Rachel J. Gorwitz, Daniel B. Jernigan, John A. Jernigan. (2006) Minimizing the Impact of Methicillin-resistant Staphylococcus aureus in the Community. Emerging Infectious Diseases 12:6, e1-e1
CrossRef399
Marin H Kollef, Scott T Micek. (2006) Methicillin-resistant Staphylococcus aureus: a new community-acquired pathogen?. Current Opinion in Internal Medicine 5:3, 224-231
CrossRef400
T. F. Jones, C. B. Creech, P. Erwin, S. G. Baird, A. M. Woron, W. Schaffner. (2006) Family Outbreaks of Invasive Community-Associated Methicillin-Resistant Staphylococcus aureus Infection. Clinical Infectious Diseases 42:9, e76-e78
CrossRef401
Ariaki Nagayama. (2006) Inactivation of influenza A virus by gentian violet (GV) and GV-dyed cotton cloth, and bactericidal activities of these agents. Journal of Infection and Chemotherapy 12:2, 73-79
CrossRef402
J. W. Smith, P. Chalupa, M. Shabaz Hasan. (2006) Infectious arthritis: clinical features, laboratory findings and treatment. Clinical Microbiology and Infection 12:4, 309-314
CrossRef403
Traci L Hedrick, Melissa M Anastacio, Robert G Sawyer. (2006) Prevention of surgical site infections. Expert Review of Anti-infective Therapy 4:2, 223-233
CrossRef404
Michael Z. David, Susan E. Crawford, Susan Boyle-Vavra, Mark A. Hostetler, Daniel C. Kim, Robert S. Daum. (2006) Contrasting Pediatric and Adult Methicillin-resistant Staphylococcus aureus Isolates. Emerging Infectious Diseases 12:4, 631-637
CrossRef405
L. J. Strausbaugh, J. D. Siegel, R. A. Weinstein, R. A. Weinstein. (2006) Preventing Transmission of Multidrug-Resistant Bacteria in Health Care Settings: A Tale of Two Guidelines. Clinical Infectious Diseases 42:6, 828-835
CrossRef406
B. Hota. (2006) Infection Control or Formulary Control: What Is the Best Tool to Reduce Nosocomial Infections due to Methicillin-Resistant Staphylococcus aureus?. Clinical Infectious Diseases 42:6, 785-787
CrossRef407
M. J. Rybak. (2006) The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria. Clinical Microbiology and Infection 12:s1, 24-32
CrossRef408
Patrick Marquis, Benoit Arnould, Catherine Acquadro, W. Mark Roberts. (2006) Patient-reported outcomes and health-related quality of life in effectiveness studies: pros and cons. Drug Development Research 67:3, 193-201
CrossRef409
M. F. Q. Kluytmans-VandenBergh, J. A. J. W. Kluytmans. (2006) Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clinical Microbiology and Infection 12:s1, 9-15
CrossRef410
Zeina A. Kanafani, Vance G. Fowler. (2006) Staphylococcus aureus Infections: New Challenges from an Old Pathogen. Enfermedades Infecciosas y Microbiología Clínica 24:3, 182-193
CrossRef411
Lisa G. Winston, Ann F. Bolger. (2006) Modern epidemiology, prophylaxis, and diagnosis and therapy for infective endocarditis. Current Cardiology Reports 8:2, 102-108
CrossRef412
U. Seybold, E. V. Kourbatova, J. G. Johnson, S. J. Halvosa, Y. F. Wang, M. D. King, S. M. Ray, H. M. Blumberg. (2006) Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Genotype as a Major Cause of Health Care--Associated Blood Stream Infections. Clinical Infectious Diseases 42:5, 647-656
CrossRef413
John F Marcinak, Arthur L Frank. (2006) Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children. Expert Review of Anti-infective Therapy 4:1, 91-100
CrossRef414
E. Tacconelli. (2006) New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission. Clinical Microbiology and Infection 12:2, 102-109
CrossRef415
Matthew E. Levison, Shirley Fung. (2006) Community-associated methicillin-resistant Staphylococcus aureus: Reconsideration of therapeutic options. Current Infectious Disease Reports 8:1, 23-30
CrossRef416
R. M. Klevens, J. R. Edwards, F. C. Tenover, L. C. McDonald, T. Horan, R. Gaynes, . (2006) Changes in the Epidemiology of Methicillin-Resistant Staphylococcus aureus in Intensive Care Units in US Hospitals, 1992-2003. Clinical Infectious Diseases 42:3, 389-391
CrossRef417
M Haas. (2006) Hypertension, race, and glomeruli: more than simply a numbers game. Kidney International 69:4, 640-642
CrossRef418
George G Zhanel, James A Karlowsky, Ethan Rubinstein, Daryl J Hoban. (2006) Tigecycline: a novel glycylcycline antibiotic. Expert Review of Anti-infective Therapy 4:1, 9-25
CrossRef419
Aaron Lin, Nicolas Y. Busaba. (2006) Staphylococcus aureus and endoscopic sinus surgery. Current Opinion in Otolaryngology & Head and Neck Surgery 14:1, 19-22
CrossRef420
Matthew Sherwood, Dustin Smith, Ryan Crisel, Emir Veledar, Stamatios Lerakis. (2006) Staphylococcus aureus Endocarditis: The Grady Memorial Hospital Experience. The American Journal of the Medical Sciences 331:2, 84-87
CrossRef421
Sharon L. Kleinschmidt, Wendy J. Munckhof, Graeme R. Nimmo. (2006) In vitro exposure of community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains to vancomycin: does vancomycin resistance occur?. International Journal of Antimicrobial Agents 27:2, 168-170
CrossRef422
M.A. Morrison, J.C. Hageman, R.M. Klevens. (2006) Case definition for community-associated methicillin-resistant Staphylococcus aureus. Journal of Hospital Infection 62:2, 241
CrossRef423
L. C. McDonald. (2006) Trends in Antimicrobial Resistance in Health Care-Associated Pathogens and Effect on Treatment. Clinical Infectious Diseases 42:Supplement 2, S65-S71
CrossRef424
Michael S. Avidan. (2006) Perioperative Bugs, Prions, and Virions. ASA Refresher Courses in Anesthesiology 34:1, 21-29
CrossRef425
Takashi Kitahara, Yuko Aoyama, Yoichi Hirakata, Shimeru Kamihira, Shigeru Kohno, Nobuhiro Ichikawa, Mikiro Nakashima, Hitoshi Sasaki, Shun Higuchi. (2006) In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA). International Journal of Antimicrobial Agents 27:1, 51-57
CrossRef426
P. Del Giudice, V. Blanc, F. Durupt, M. Bes, J-P. Martinez, E. Counillon, G. Lina, F. Vandenesch, J. Etienne. (2006) Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. British Journal of Dermatology 154:1, 118-124
CrossRef427
E. Yoko Furuya, Franklin D. Lowy. (2006) Antimicrobial-resistant bacteria in the community setting. Nature Reviews Microbiology 4:1, 36-45
CrossRef428
Stan Deresinski. (2006) Antistaphylococcal Vaccines and Immunoglobulins. Drugs 66:14, 1797-1806
CrossRef429
Amparo Broseta, Fernando Chaves, Pablo Rojo, Joaquín R. Otero. (2006) Emergencia de un clon de Staphylococcus aureus resistente a meticilina de origen comunitario en la población pediátrica del sur de Madrid. Enfermedades Infecciosas y Microbiología Clínica 24:1, 31-35
CrossRef430
Evan J Anderson, Claudia Hawkins, Maureen K Bolon, Frank J Palella. (2006) A Series of Skin and Soft Tissue Infections Due to Methicillin-Resistant Staphylococcus aureus in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes 41:1, 125-127
CrossRef431
Stephen H Zinner. (2005) The search for new antimicrobials: why we need new options. Expert Review of Anti-infective Therapy 3:6, 907-913
CrossRef432
Michael W Ellis, James S Lewis. (2005) Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections. Current Opinion in Infectious Diseases 18:6, 496-501
CrossRef433
Richard G. Wunderink. (2005) Evaluación de los pacientes con neumonía nosocomial y falta de respuesta al tratamiento. Enfermedades Infecciosas y Microbiología Clínica 23, 52-57
CrossRef434
John J. Ross. (2005) Septic Arthritis. Infectious Disease Clinics of North America 19:4, 799-817
CrossRef435
John S. Francis, Karen Carroll. (2005) Community-acquired MRSA: A Notable Adversary. Southern Medical Journal 98:11, 1061-1062
CrossRef436
Ekopimo Ibia. (2005) Methicillin-resistant Staphylococcus aureus Pneumonia in Children: A Call for Increased Vigilance. Southern Medical Journal 98:11, 1059-1060
CrossRef437
Benjamin A Lipsky, David G Armstrong, Diane M Citron, Alan D Tice, David E Morgenstern, Murray A Abramson. (2005) Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. The Lancet 366:9498, 1695-1703
CrossRef438
Valentina Molteni, Andreas Kreusch. (2005) Peptide deformylase inhibitors: a survey of the patent literature. Expert Opinion on Therapeutic Patents 15:10, 1423-1437
CrossRef439
Jessica M. Buck, Kathryn Como-Sabetti, Kathleen H. Harriman, Richard N. Danila, David J. Boxrud, Anita Glennen, Ruth Lynfield. (2005) Community-associated Methicillin-resistant Staphylococcus aureus , Minnesota, 2000–2003. Emerging Infectious Diseases 11:10, 1532-1538
CrossRef440
Philip S. Barie. (2005) Another Scourge Upon the Populace: Community- Associated Methicillin-Resistant Staphylococcus aureus. Surgical Infections 6:3, 265-267
CrossRef441
Sheldon L. Kaplan. (2005) Implications of Methicillin-Resistant Staphylococcus aureus as a Community-Acquired Pathogen in Pediatric Patients. Infectious Disease Clinics of North America 19:3, 747-757
CrossRef442
James S. Tan. (2005) New antimicrobial agents active against Staphylococcus aureus. Current Infectious Disease Reports 7:5, 357-358
CrossRef443
Ronald L. Nichols, Robert E. Condon, Philip S. Barie. (2005) Antibiotic Prophylaxis in Surgery—2005 and Beyond. Surgical Infections 6:3, 349-361
CrossRef444
(2005) MRSA in the Community. New England Journal of Medicine 353:5, 530-532
Full Text445
W. Witte, M. Wiese-Posselt, U. Jappe. (2005) Community MRSA. Der Hautarzt 56:8, 731-738
CrossRef446
Emma Marris. (2005) Bugs gain vital ground in their battle against drugs. Nature Medicine 11:5, 461-461
CrossRef447
Chambers, Henry F., . (2005) Community-Associated MRSA — Resistance and Virulence Converge. New England Journal of Medicine 352:14, 1485-1487
Full Text
- Letters
